Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 5: Student Goals and Expectations by Level of Instruction The Modern Language Journal. 98: 128-162. DOI: 10.1111/J.1540-4781.2013.12056_8.X |
0.251 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 8: Standards Through the Perspectives of Postsecondary Students The Modern Language Journal. 98: 222-251. DOI: 10.1111/J.1540-4781.2013.2056_11.X |
0.247 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 3: Student Goals and Hierarchies The Modern Language Journal. 98: 64-97. DOI: 10.1111/J.1540-4781.2013.12056_6.X |
0.247 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 6: Student Goals and Expectations by More and Less Commonly Taught Languages The Modern Language Journal. 98: 163-192. DOI: 10.1111/J.1540-4781.2013.12056_9.X |
0.247 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 4: Student Expectations and Hierarchies The Modern Language Journal. 98: 98-127. DOI: 10.1111/J.1540-4781.2013.12056_7.X |
0.245 |
|
2012 |
Magnan SS, Murphy D, Sahakyan N, Kim S. Student Goals, Expectations, and the Standards for Foreign Language Learning Foreign Language Annals. 45: 170-192. DOI: 10.1111/J.1944-9720.2012.01192.X |
0.241 |
|
2015 |
Picchioni M, Harris S, Surgladze S, Reichenberg AVI, Murphy D. A Neuro-psychological Model of Violence Propensity in Schizophrenia European Psychiatry. 30: 293. DOI: 10.1016/S0924-9338(15)30236-4 |
0.22 |
|
2014 |
Murphy D, Sahakyan N, Yong-Yi D, Magnan SS. The Impact of Study Abroad on the Global Engagement of University Graduates. Frontiers: the Interdisciplinary Journal of Study Abroad. 24: 1-24. DOI: 10.36366/Frontiers.V24I1.333 |
0.215 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 1: Considering the Standards for Foreign Language Learning in Postsecondary Instruction The Modern Language Journal. 98: 12-39. DOI: 10.1111/J.1540-4781.2013.12056_4.X |
0.207 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 2: Describing the Study The Modern Language Journal. 98: 40-63. DOI: 10.1111/J.1540-4781.2013.12056_5.X |
0.202 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. Introduction Modern Language Journal. 98: 1-11. DOI: 10.1111/J.1540-4781.2013.12056_3.X |
0.201 |
|
2014 |
Magnan SS, Murphy D, Sahakyan N. CHAPTER 7: Beyond Hierarchies, Beyond Standards The Modern Language Journal. 98: 193-221. DOI: 10.1111/J.1540-4781.2013.2056_10.X |
0.194 |
|
1985 |
Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL. Obsessive-compulsive disorder and serotonin: is there a connection? Biological Psychiatry. 20: 1174-88. PMID 2413912 DOI: 10.1016/0006-3223(85)90176-3 |
0.192 |
|
1979 |
Murphy DL, Campbell IC, Costa JL. The brain serotonergic system in the affective disorders. Progress in Neuro-Psychopharmacology. 2: 5-31. PMID 214806 DOI: 10.1016/0364-7722(78)90019-X |
0.189 |
|
1989 |
Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Archives of General Psychiatry. 46: 23-8. PMID 2910220 DOI: 10.1001/Archpsyc.1989.01810010025004 |
0.187 |
|
1999 |
Schwartz PJ, Turner EH, Garcia-Borreguero D, Sedway J, Vetticad RG, Wehr TA, Murphy DL, Rosenthal NE. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects. Psychiatry Research. 86: 9-28. PMID 10359479 DOI: 10.1016/S0165-1781(99)00017-7 |
0.184 |
|
2003 |
Murphy D. Introducing the Listening Assistant The Iallt Journal of Language Learning Technologies. 35: 65-70. DOI: 10.17161/Iallt.V35I2.8388 |
0.183 |
|
1992 |
Brewerton TD, Murphy DL, Lesem MD, Brandt HA, Jimerson DC. Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache. 32: 217-22. PMID 1628957 DOI: 10.1111/j.1526-4610.1992.hed3205217.x |
0.183 |
|
1990 |
Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL. Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder: Behavioral and Biological Results Archives of General Psychiatry. 47: 926-932. PMID 2222131 DOI: 10.1001/Archpsyc.1990.01810220042005 |
0.181 |
|
1997 |
McCann UD, Morgan CM, Geraci M, Slate SO, Murphy DL, Post RM. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 360-9. PMID 9397424 DOI: 10.1016/S0893-133X(97)00085-7 |
0.178 |
|
1992 |
Murphy DL, Broocks A, Aulakh CS, Pigott TA. Anxiolytic effects of drugs acting on 5-HT receptor subtypes European Neuropsychopharmacology. 2: 287-288. DOI: 10.1016/0924-977X(92)90120-W |
0.178 |
|
1989 |
Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. The British Journal of Psychiatry. Supplement. 15-24. PMID 2692636 DOI: 10.1192/S0007125000291721 |
0.177 |
|
1992 |
PIGOTT TA, L??HEUREUX F, RUBENSTEIN CS, BERNSTEIN SE, HILL JL, MURPHY DL. A Double-Blind, Placebo Controlled Study of Trazodone Journal of Clinical Psychopharmacology. 12: 156???162. DOI: 10.1097/00004714-199206000-00002 |
0.177 |
|
1998 |
Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL. Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology. 140: 434-44. PMID 9888619 DOI: 10.1007/S002130050787 |
0.176 |
|
1984 |
Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL. Biological markers in obsessive-compulsive and affective disorders. Journal of Psychiatric Research. 18: 407-23. PMID 6512711 DOI: 10.1016/0022-3956(84)90030-X |
0.175 |
|
1999 |
Bengel D, Greenberg BD, Corá-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Molecular Psychiatry. 4: 463-6. PMID 10523819 DOI: 10.1038/Sj.Mp.4000550 |
0.174 |
|
1993 |
Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenstein CS, Murphy DL. A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP. Biological Psychiatry. 33: 3-14. PMID 8420593 DOI: 10.1016/0006-3223(93)90272-F |
0.173 |
|
1975 |
Goodwin FK, Murphy DL. Chapter 5. Biological Factors in the Major Psychoses Annual Reports in Medicinal Chemistry. 10: 39-50. DOI: 10.1016/S0065-7743(08)60993-8 |
0.173 |
|
1997 |
Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren DA, Moul DE, Ozaki N, Snelbaker AJ, Rosenthal NE. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms. Archives of General Psychiatry. 54: 375-85. PMID 9107154 DOI: 10.1001/Archpsyc.1997.01830160103013 |
0.172 |
|
1992 |
Brewerton TD, Mueller EA, Lesem MD, Brandt HA, Quearry B, George DT, Murphy DL, Jimerson DC. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Archives of General Psychiatry. 49: 852-61. PMID 1444722 DOI: 10.1001/Archpsyc.1992.01820110016002 |
0.172 |
|
1997 |
Greenberg BD, Altemus M, Murphy DL. The role of neurotransmitters and neurohormones in obsessive-compulsive disorder International Review of Psychiatry. 9: 31-44. DOI: 10.1080/09540269775574 |
0.171 |
|
1998 |
Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL. Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results. Psychiatry Research. 79: 11-20. PMID 9676822 DOI: 10.1016/S0165-1781(98)00029-8 |
0.171 |
|
2004 |
Murphy DL, Lerner A, Rudnick G, Lesch KP. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Molecular Interventions. 4: 109-23. PMID 15087484 DOI: 10.1124/Mi.4.2.8 |
0.171 |
|
1980 |
Haier RJ, Buchsbaum MS, Murphy DL. An 18-month followup of students biologically at risk for psychiatric problems. Schizophrenia Bulletin. 6: 334-7. PMID 7375866 DOI: 10.1093/Schbul/6.2.334 |
0.17 |
|
1993 |
Murphy DL, Pigott TA, Grady TA, Lawlor B, Broocks A, Jacobsen F, Rosenthal N, Aulakh C, Lesch KP, Sunderland T. Affective, behavioral, and other non-endocrine physiologic responses to 5-HT 1 2 agonists and antagonists in humans European Neuropsychopharmacology. 3: 308-309. DOI: 10.1016/0924-977X(93)90089-5 |
0.17 |
|
1987 |
Murphy DL, Aulakh CS, Garrick NA. How antidepressants work: cautionary conclusions based on clinical and laboratory studies of the longer-term consequences of antidepressant drug treatment. Ciba Foundation Symposium. 123: 106-25. PMID 3028721 DOI: 10.1002/9780470513361.CH7 |
0.169 |
|
2003 |
Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2077-88. PMID 12968128 DOI: 10.1038/sj.npp.1300266 |
0.168 |
|
1987 |
Flament MF, Rapoport JL, Murphy DL, Berg CJ, Lake CR. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry. 44: 219-25. PMID 3548637 DOI: 10.1001/Archpsyc.1987.01800150025004 |
0.168 |
|
1995 |
Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder Biological Psychiatry. 37: 215-223. PMID 7711157 DOI: 10.1016/0006-3223(94)00147-U |
0.168 |
|
1985 |
Murphy DL, Siever LJ, Insel TR. Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 3-13. PMID 2986199 DOI: 10.1016/0278-5846(85)90174-5 |
0.168 |
|
1980 |
Haier RJ, Buchsbaum MS, Murphy DL, Gottesman II, Coursey RD. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential. Archives of General Psychiatry. 37: 340-5. PMID 7362421 DOI: 10.1001/Archpsyc.1980.01780160110013 |
0.166 |
|
1988 |
Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. Archives of General Psychiatry. 45: 167-72. PMID 3276283 DOI: 10.1001/Archpsyc.1988.01800260081011 |
0.165 |
|
1993 |
Altemus M, Pigott T, L'Heureux F, Davis CL, Rubinow DR, Murphy DL, Gold PW. CSF somatostatin in obsessive-compulsive disorder American Journal of Psychiatry. 150: 460-464. PMID 8094599 DOI: 10.1176/Ajp.150.3.460 |
0.165 |
|
1991 |
Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder American Journal of Psychiatry. 148: 127-129. PMID 1984696 DOI: 10.1176/Ajp.148.1.127 |
0.165 |
|
1982 |
Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder American Journal of Psychiatry. 139: 1315-1318. PMID 6289682 |
0.165 |
|
1990 |
MURPHY DL, PATO MT, PIGOTT TA. Obsessive-Compulsive Disorder Journal of Clinical Psychopharmacology. 10: 91S-100S. DOI: 10.1097/00004714-199006001-00016 |
0.164 |
|
1994 |
Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JL, Murphy DL. Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Research. 52: 181-97. PMID 7972574 DOI: 10.1016/0165-1781(94)90087-6 |
0.164 |
|
1983 |
Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry. 40: 605-12. PMID 6342562 DOI: 10.1001/Archpsyc.1983.04390010015002 |
0.163 |
|
1989 |
Bagdy G, Calogero AE, Aulakh CS, Szemeredi K, Murphy DL. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. Neuroendocrinology. 50: 241-7. PMID 2552339 DOI: 10.1159/000125248 |
0.163 |
|
1990 |
Mellow AM, Lawlor BA, Sunderland T, Mueller EA, Molchan SE, Murphy DL. Effects of daily oral m-chlorophenylpiperazine in elderly depressed patients. Initial experience with a serotonin agonist. Biological Psychiatry. 28: 588-94. PMID 2223928 DOI: 10.1016/0006-3223(90)90396-J |
0.162 |
|
1987 |
Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Archives of General Psychiatry. 44: 946-51. PMID 3675134 DOI: 10.1001/Archpsyc.1987.01800230026006 |
0.162 |
|
1985 |
Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL. Tricyclic response in obsessive compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 25-31. PMID 3991911 DOI: 10.1016/0278-5846(85)90176-9 |
0.16 |
|
1992 |
Bihari K, Pigott TA, Hill JL, Murphy DL. Blepharospasm and obsessive-compulsive disorder. The Journal of Nervous and Mental Disease. 180: 130-2. PMID 1737975 DOI: 10.1097/00005053-199202000-00011 |
0.16 |
|
1981 |
Kalin NH, Risch SC, Murphy DL. Involvement of the central serotonergic system in affective illness. Journal of Clinical Psychopharmacology. 1: 232-7. PMID 7028804 DOI: 10.1097/00004714-198107000-00008 |
0.159 |
|
2009 |
Züchner S, Wendland JR, Ashley-Koch AE, Collins AL, Tran-Viet KN, Quinn K, Timpano KC, Cuccaro ML, Pericak-Vance MA, Steffens DC, Krishnan KR, Feng G, Murphy DL. Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Molecular Psychiatry. 14: 6-9. PMID 19096451 DOI: 10.1038/Mp.2008.83 |
0.158 |
|
2003 |
Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry. 54: 953-9. PMID 14625137 DOI: 10.1016/J.Biopsych.2003.09.003 |
0.158 |
|
1996 |
Benjamin J, Greenberg BD, Murphy DL. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects. Psychopharmacology. 127: 140-9. PMID 8888380 DOI: 10.1007/Bf02805987 |
0.157 |
|
1996 |
Bonson KR, Buckholtz JW, Murphy DL. Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans Neuropsychopharmacology. 14: 425-436. PMID 8726753 DOI: 10.1016/0893-133X(95)00145-4 |
0.157 |
|
1988 |
Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine. Clinical Pharmacology and Therapeutics. 43: 605-9. PMID 3378382 DOI: 10.1038/Clpt.1988.83 |
0.157 |
|
2011 |
Murphy DL, Moya PR. Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease. Current Opinion in Pharmacology. 11: 3-10. PMID 21439906 DOI: 10.1016/J.Coph.2011.02.008 |
0.157 |
|
1985 |
Siever LJ, Uhde TW, Insel TR, Kaye WH, Jimerson DC, Lake CR, Kafka M, Targum S, Murphy DL. Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 15-24. PMID 2986198 DOI: 10.1016/0278-5846(85)90175-7 |
0.156 |
|
1995 |
Rubenstein CS, Altemus M, Pigott TA, Hess A, Murphy DL. Symptom overlap between OCD and bulimia nervosa Journal of Anxiety Disorders. 9: 1-9. DOI: 10.1016/0887-6185(95)91551-R |
0.155 |
|
1999 |
Murphy DL, Wichems C, Li Q, Heils A. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends in Pharmacological Sciences. 20: 246-52. PMID 10366867 DOI: 10.1016/S0165-6147(99)01325-5 |
0.154 |
|
2008 |
Murphy DL. Clinical, Genetic, Hormonal and Drug Influences on the Activity of Human Platelet Monoamine Oxidase Monoamine Oxidase and Its Inhibition. 341-351. DOI: 10.1002/9780470720219.ch17 |
0.154 |
|
1982 |
Siever LJ, Uhde TW, Silberman EK, Jimerson DC, Aloi JA, Post RM, Murphy DL. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Research. 6: 171-83. PMID 6283576 DOI: 10.1016/0165-1781(82)90005-1 |
0.153 |
|
1982 |
Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Research. 6: 153-60. PMID 6953457 DOI: 10.1016/0165-1781(82)90003-8 |
0.153 |
|
1989 |
Bagdy G, Calogero AE, Murphy DL, Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology. 125: 2664-9. PMID 2551661 DOI: 10.1210/Endo-125-5-2664 |
0.153 |
|
1993 |
Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 150: 819-21. PMID 8480832 DOI: 10.1176/Ajp.150.5.819 |
0.153 |
|
1993 |
Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biological Psychiatry. 33: 496-504. PMID 8390305 DOI: 10.1016/0006-3223(93)90003-V |
0.153 |
|
1992 |
Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW. Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive Disorder Archives of General Psychiatry. 49: 9-20. PMID 1370198 DOI: 10.1001/Archpsyc.1992.01820010009002 |
0.152 |
|
1976 |
Buchsbaum MS, Coursey RD, Murphy DL. The biochemical high risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity Science. 194: 339-341. PMID 968488 DOI: 10.1126/Science.968488 |
0.15 |
|
2012 |
Guiard BP, Mansari ME, Murphy DL, Blier P. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 349-61. PMID 21439106 DOI: 10.1017/S1461145711000484 |
0.15 |
|
1996 |
Murphy DL, Aulakh C, Mazzola-Pomietto P, Briggs NC. Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: a preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behavioural Brain Research. 73: 209-14. PMID 8788504 DOI: 10.1016/0166-4328(96)00098-8 |
0.15 |
|
2006 |
Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, Jaing C, Murphy DL, Lanthorn TH, Holmes A. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience. 140: 321-34. PMID 16542782 DOI: 10.1016/J.Neuroscience.2006.01.049 |
0.149 |
|
1974 |
Murphy DL, Baker M, Goodwin FK, Miller H, Kotin J, Bunney WE. l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects Psychopharmacology. 34: 11-20. PMID 4593517 DOI: 10.1007/Bf00421216 |
0.149 |
|
1991 |
Benkelfat C, Mefford IN, Masters CF, Nordahl TE, King AC, Cohen RM, Murphy DL. Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Psychiatry Research. 37: 321-31. PMID 1891512 DOI: 10.1016/0165-1781(91)90067-Y |
0.148 |
|
1989 |
Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 145: 1521-5. PMID 3057923 DOI: 10.1176/Ajp.145.12.1521 |
0.148 |
|
1999 |
Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics. 88: 83-7. PMID 10050973 DOI: 10.1002/(Sici)1096-8628(19990205)88:1<83::Aid-Ajmg15>3.0.Co;2-0 |
0.148 |
|
2001 |
Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch KP, Uhl G. Genetic perspectives on the serotonin transporter. Brain Research Bulletin. 56: 487-94. PMID 11750794 DOI: 10.1016/S0361-9230(01)00622-0 |
0.148 |
|
1992 |
Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biological Psychiatry. 30: 973-84. PMID 1756202 DOI: 10.1016/0006-3223(91)90119-7 |
0.147 |
|
1976 |
Murphy DL. Chapter 5: Biological Factors in Psychiatric Disorders Annual Reports in Medicinal Chemistry. 11: 42-50. DOI: 10.1016/S0065-7743(08)61388-3 |
0.146 |
|
2008 |
Kalueff AV, LaPorte JL, Murphy DL. Perspectives on genetic animal models of serotonin toxicity. Neurochemistry International. 52: 649-58. PMID 17935833 DOI: 10.1016/J.Neuint.2007.08.015 |
0.146 |
|
1993 |
Andrews AM, Murphy DL. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine. European Journal of Pharmacology. 250: 215-21. PMID 8112382 DOI: 10.1016/0014-2999(93)90384-T |
0.146 |
|
1998 |
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Molecular Pharmacology. 53: 649-55. PMID 9547354 DOI: 10.1124/Mol.53.4.649 |
0.146 |
|
2015 |
Igari M, Shen HW, Hagino Y, Fukushima S, Kasahara Y, Lesch KP, Murphy DL, Hall FS, Uhl GR, Ikeda K, Yaegashi N, Sora I. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment. Behavioural Pharmacology. 26: 167-79. PMID 25485646 DOI: 10.1097/Fbp.0000000000000120 |
0.146 |
|
1996 |
Altemus M, Murphy DL, Greenberg B, Lesch KP. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. American Journal of Medical Genetics. 67: 409-11. PMID 8837711 DOI: 10.1002/(Sici)1096-8628(19960726)67:4<409::Aid-Ajmg16>3.0.Co;2-N |
0.146 |
|
2008 |
Fox MA, Jensen CL, French HT, Stein AR, Huang SJ, Tolliver TJ, Murphy DL. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology. 201: 203-18. PMID 18712364 DOI: 10.1007/S00213-008-1268-7 |
0.145 |
|
1992 |
Pigott TA, L’Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder Journal of Clinical Psychopharmacology. 12: 11-18. PMID 1552034 DOI: 10.1097/00001573-199202000-00003 |
0.145 |
|
1996 |
Grady TA, Broocks A, Canter SK, Pigott TA, Dubbert B, Hill JL, Murphy DL. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers. Psychiatry Research. 64: 1-10. PMID 8888359 DOI: 10.1016/0165-1781(96)02884-3 |
0.145 |
|
2001 |
Meiri G, Ben-Zion IZ, Greenberg BD, Murphy DL, Benjamin J. Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers. Human Psychopharmacology. 16: 237-245. PMID 12404576 DOI: 10.1002/Hup.259 |
0.145 |
|
1978 |
Buchsbaum MS, Murphy DL, Coursey RD, Lake CR, Zeigler MG. Platelet monoamine oxidase, plasma dopamine-beta-hydroxylase and attention in a "biochemical high risk" sample. Journal of Psychiatric Research. 14: 215-24. PMID 722628 DOI: 10.1016/0022-3956(78)90024-9 |
0.145 |
|
1992 |
Bihari K, Hill JL, Murphy DL. Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollis. Psychiatry Research. 42: 267-72. PMID 1496058 DOI: 10.1016/0165-1781(92)90118-M |
0.145 |
|
1983 |
Siever LJ, Uhde TW, Jimerson DC, Kafka MS, Lake CR, Targum S, Murphy DL. Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 249-61. PMID 6310694 DOI: 10.1016/0278-5846(83)90115-X |
0.145 |
|
1981 |
Risch SC, Cohen RM, Janowsky DS, Kalin NH, Sitaram N, Gillin JC, Murphy DL. Physostigmine induction of depressive symptomatology in normal human subjects. Psychiatry Research. 4: 89-94. PMID 7012883 DOI: 10.1016/0165-1781(81)90012-3 |
0.144 |
|
1979 |
Coursey RD, Buchsbaum MS, Murphy DL. Platelet MAO activity and evoked potentials in the identification of subjects biologically at risk for psychiatric disorders. The British Journal of Psychiatry : the Journal of Mental Science. 134: 372-81. PMID 444787 DOI: 10.1192/Bjp.134.4.372 |
0.144 |
|
2002 |
Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL. Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology. 143: 4520-6. PMID 12446578 DOI: 10.1210/En.2002-220416 |
0.143 |
|
1983 |
Siever LJ, Insel TR, Jimerson DC, Lake CR, Uhde TW, Aloi J, Murphy DL. Growth hormone response to clonidine in obsessive-compulsive patients. The British Journal of Psychiatry : the Journal of Mental Science. 142: 184-7. PMID 6839074 DOI: 10.1192/Bjp.142.2.184 |
0.143 |
|
2013 |
Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368: 20120435. PMID 23440468 DOI: 10.1098/Rstb.2012.0435 |
0.143 |
|
1989 |
Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings. Archives of General Psychiatry. 46: 205-12. PMID 2645848 DOI: 10.1001/Archpsyc.1989.01810030011002 |
0.143 |
|
2014 |
Sakakibara Y, Kasahara Y, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I. Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice. Psychopharmacology. 231: 4119-33. PMID 24728652 DOI: 10.1007/S00213-014-3554-X |
0.143 |
|
1972 |
Murphy DL, Weiss R. Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. The American Journal of Psychiatry. 128: 1351-7. PMID 5020182 DOI: 10.1176/Ajp.128.11.1351 |
0.142 |
|
1996 |
Bonson KR, Murphy DL. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behavioural Brain Research. 73: 229-33. PMID 8788508 DOI: 10.1016/0166-4328(96)00102-7 |
0.142 |
|
2007 |
Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology. 195: 147-66. PMID 17712549 DOI: 10.1007/S00213-007-0910-0 |
0.142 |
|
2007 |
Samuels JF, Bienvenu OJ, Pinto A, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Greenberg BD, Knowles JA, Piacentini J, Cannistraro PA, Cullen B, Riddle MA, Rasmussen SA, et al. Hoarding in obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Behaviour Research and Therapy. 45: 673-86. PMID 16824483 DOI: 10.1016/J.Brat.2006.05.008 |
0.142 |
|
1989 |
Aulakh CS, Cohen RM, Dauphin MM, McLellan CA, Murphy DL. Role of serotonergic input in the down-regulation of beta-adrenoceptors following long-term clorgyline treatment. European Journal of Pharmacology. 156: 63-70. PMID 2463178 DOI: 10.1016/0014-2999(88)90147-1 |
0.142 |
|
1985 |
Mueller EA, Murphy DL, Sunderland T. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. The Journal of Clinical Endocrinology and Metabolism. 61: 1179-84. PMID 4055985 DOI: 10.1210/Jcem-61-6-1179 |
0.142 |
|
2010 |
Brigman JL, Mathur P, Harvey-White J, Izquierdo A, Saksida LM, Bussey TJ, Fox S, Deneris E, Murphy DL, Holmes A. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cerebral Cortex (New York, N.Y. : 1991). 20: 1955-63. PMID 20032063 DOI: 10.1093/Cercor/Bhp266 |
0.141 |
|
1989 |
Lawlor BA, Sunderland T, Mellow AM, Hill JL, Newhouse PA, Murphy DL. A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects. Biological Psychiatry. 25: 679-86. PMID 2923931 DOI: 10.1016/0006-3223(89)90237-0 |
0.141 |
|
1994 |
Ozaki N, Rosenthal NE, Mazzola P, Chiueh CC, Hardin T, Garcia-Borreguero D, Schwartz PJ, Turner E, Oren DA, Murphy DL. Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder. Biological Psychiatry. 36: 458-66. PMID 7811842 DOI: 10.1016/0006-3223(94)90641-6 |
0.141 |
|
1998 |
Lenders JW, Brunner HG, Murphy DL, Eisenhofer G. Genetic deficiencies of monoamine oxidase enzymes: a key to understanding the function of the enzymes in humans. Advances in Pharmacology (San Diego, Calif.). 42: 297-301. PMID 9327899 DOI: 10.1016/S1054-3589(08)60748-6 |
0.141 |
|
1983 |
SIEVER LJ, PICKAR D, LAKE R, COHEN RM, UHDE TW, MURPHY DL. Extreme Elevations in Plasma Norepinephrine Associated with Decreased ??-Adrenergic Responsivity in Major Depressive Disorder Journal of Clinical Psychopharmacology. 3: 39???41. DOI: 10.1097/00004714-198302000-00010 |
0.141 |
|
1991 |
Coccaro EF, Murphy DL. Serotonin in Major Psychiatric Disorders (Progress in Psychiatry Series) International Clinical Psychopharmacology. 6: 125. DOI: 10.1097/00004850-199100620-00008 |
0.141 |
|
1997 |
Rubinow D, Schmidt P, Zhang L, Roca C, Su T, Greenberg B, Murphy D. Gonadal steroids and serotonin: Development and treatment of mood disorders Biological Psychiatry. 42: 6S. DOI: 10.1016/S0006-3223(97)86889-8 |
0.14 |
|
1997 |
Broocks A, Briggs NC, Pigott TA, Hill JL, Canter SK, Tolliver TJ, Baldemore D, Murphy DL. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment. Psychopharmacology. 130: 91-103. PMID 9106905 DOI: 10.1007/S002130050215 |
0.14 |
|
2019 |
Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, Mclaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, Mccracken JT, Piacentini J, ... ... Murphy DL, et al. General personality dimensions, impairment and treatment response in obsessive-compulsive disorder. Personality and Mental Health. PMID 31859455 DOI: 10.1002/Pmh.1472 |
0.14 |
|
2007 |
Wendland JR, Kruse MR, Cromer KR, Cromer KC, Murphy DL. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2543-51. PMID 17375136 DOI: 10.1038/Sj.Npp.1301394 |
0.14 |
|
1975 |
Donnelly EF, Murphy DL, Scott WH. Perception and cognition in patients with bipolar and unipolar depressive disorders. A study in orschach responding. Archives of General Psychiatry. 32: 1128-31. PMID 1180662 DOI: 10.1001/Archpsyc.1975.01760270060006 |
0.14 |
|
1991 |
Lawlor BA, Sunderland T, Mellow AM, Molchan SE, Martinez R, Murphy DL. A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease. Biological Psychiatry. 30: 140-4. PMID 1912105 DOI: 10.1016/0006-3223(91)90167-K |
0.14 |
|
1977 |
Leckman JF, Gershon ES, Nichols AS, Murphy DL. Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report. Archives of General Psychiatry. 34: 601-6. PMID 871234 DOI: 10.1001/Archpsyc.1977.01770170111011 |
0.139 |
|
2003 |
Murphy DL, Uhl GR, Holmes A, Ren-Patterson R, Hall FS, Sora I, Detera-Wadleigh S, Lesch KP. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes, Brain, and Behavior. 2: 350-64. PMID 14653307 DOI: 10.1046/j.1601-1848.2003.00049.x |
0.139 |
|
2004 |
Li Q, Ma L, Innis RB, Seneca N, Ichise M, Huang H, Laruelle M, Murphy DL. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB). The Journal of Pharmacology and Experimental Therapeutics. 308: 481-6. PMID 14610240 DOI: 10.1124/Jpet.103.058636 |
0.139 |
|
1991 |
Murphy DL, Sims KB, Karoum F, Garrick NA, de la Chapelle A, Sankila EM, Norio R, Breakefield XO. Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. Journal of Neural Transmission. General Section. 83: 1-12. PMID 2018626 DOI: 10.1007/Bf01244447 |
0.139 |
|
2008 |
Carneiro AM, Cook EH, Murphy DL, Blakely RD. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. The Journal of Clinical Investigation. 118: 1544-52. PMID 18317590 DOI: 10.1172/Jci33374 |
0.139 |
|
1977 |
Murphy DL. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Advances in Pharmacology and Chemotherapy. 14: 71-105. PMID 18913 DOI: 10.1016/S1054-3589(08)60185-4 |
0.139 |
|
2003 |
Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Molecular Psychiatry. 8: 933-6. PMID 14593431 DOI: 10.1038/Sj.Mp.4001365 |
0.139 |
|
1993 |
Andrews AM, Murphy DL. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP. Journal of Neurochemistry. 60: 1167-70. PMID 8094744 DOI: 10.1111/J.1471-4159.1993.Tb03271.X |
0.139 |
|
1984 |
Siever LJ, Uhde TW, Jimerson DC, Post RM, Lake CR, Murphy DL. Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Archives of General Psychiatry. 41: 63-8. PMID 6691786 DOI: 10.1001/Archpsyc.1984.01790120067009 |
0.138 |
|
1993 |
Brewerton TD, Flament MF, Rapoport JL, Murphy DL. Seasonal effects on platelet 5-HT content in patients with OCD and controls. Archives of General Psychiatry. 50: 409. PMID 8489330 DOI: 10.1001/Archpsyc.1993.01820170095015 |
0.138 |
|
2008 |
Perona MT, Waters S, Hall FS, Sora I, Lesch KP, Murphy DL, Caron M, Uhl GR. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural Pharmacology. 19: 566-74. PMID 18690111 DOI: 10.1097/Fbp.0B013E32830Cd80F |
0.137 |
|
2008 |
Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology. 55: 932-60. PMID 18824000 DOI: 10.1016/J.Neuropharm.2008.08.034 |
0.137 |
|
1973 |
Murphy DL, Mendell JR, Engel WK. Serotonin and platelet function in Duchenne muscular dystrophy. Archives of Neurology. 28: 239-42. PMID 4688430 DOI: 10.1001/Archneur.1973.00490220047006 |
0.137 |
|
2012 |
Timpano KR, Rubenstein LM, Murphy DL. Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and OCD connection. Depression and Anxiety. 29: 226-33. PMID 22109969 DOI: 10.1002/Da.20908 |
0.137 |
|
1981 |
Risch SC, Kalin NH, Murphy DL. Neurochemical mechanisms in the affective disorders and neuroendocrine correlates. Journal of Clinical Psychopharmacology. 1: 180-5. PMID 6117585 DOI: 10.1097/00004714-198107000-00002 |
0.137 |
|
2010 |
Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues in Clinical Neuroscience. 12: 131-48. PMID 20623919 |
0.137 |
|
2008 |
Wheaton M, Timpano KR, LaSalle-Ricci VH, Murphy D. Characterizing the hoarding phenotype in individuals with OCD: Associations with comorbidity, severity and gender Journal of Anxiety Disorders. 22: 243-252. PMID 17339096 DOI: 10.1016/J.Janxdis.2007.01.015 |
0.137 |
|
2017 |
González LF, Henríquez-Belmar F, Delgado-Acevedo C, Cisternas-Olmedo M, Arriagada G, Sotomayor-Zárate R, Murphy DL, Moya PR. Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice. Biological Research. 50: 29. PMID 28927446 DOI: 10.1186/S40659-017-0138-3 |
0.137 |
|
2010 |
Fox MA, French HT, LaPorte JL, Blackler AR, Murphy DL. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology. 212: 13-23. PMID 19823806 DOI: 10.1007/S00213-009-1694-1 |
0.136 |
|
2003 |
Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. The Journal of Pharmacology and Experimental Therapeutics. 307: 923-31. PMID 14561848 DOI: 10.1124/Jpet.103.055749 |
0.136 |
|
1986 |
Mueller EA, Murphy DL, Sunderland T. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology. 89: 388-91. PMID 3014595 DOI: 10.1007/Bf00174380 |
0.136 |
|
2005 |
Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch KP, Murphy DL. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology. 49: 798-810. PMID 16183083 DOI: 10.1016/J.Neuropharm.2005.08.010 |
0.136 |
|
2000 |
Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. The European Journal of Neuroscience. 12: 2299-310. PMID 10947809 DOI: 10.1046/J.1460-9568.2000.00126.X |
0.136 |
|
2003 |
Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes, Brain, and Behavior. 2: 365-80. PMID 14653308 DOI: 10.1046/J.1601-1848.2003.00050.X |
0.136 |
|
2008 |
Wendland JR, DeGuzman TB, McMahon F, Rudnick G, Detera-Wadleigh SD, Murphy DL. SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder. Psychiatric Genetics. 18: 31-9. PMID 18197083 DOI: 10.1097/Ypg.0B013E3282F08A06 |
0.136 |
|
2007 |
Kalueff AV, Murphy DL. The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plasticity. 2007: 52087. PMID 18288249 DOI: 10.1155/2007/52087 |
0.136 |
|
2007 |
Kalueff AV, Ren-Patterson RF, Murphy DL. The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends in Pharmacological Sciences. 28: 122-7. PMID 17275930 DOI: 10.1016/J.Tips.2007.01.002 |
0.136 |
|
1982 |
Donnelly EF, Murphy DL, Goodwin FK, Waldman IN. Intellectual function in primary affective disorder. The British Journal of Psychiatry : the Journal of Mental Science. 140: 633-6. PMID 7104555 DOI: 10.1192/Bjp.140.6.633 |
0.135 |
|
2013 |
Fox MA, Panessiti MG, Moya PR, Tolliver TJ, Chen K, Shih JC, Murphy DL. Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. The Pharmacogenomics Journal. 13: 551-7. PMID 22964922 DOI: 10.1038/tpj.2012.35 |
0.135 |
|
1991 |
Pigott TA, Altemus M, Rubenstein CS, Hill JL, Bihari K, L'Heureux F, Bernstein S, Murphy DL. Symptoms of eating disorders in patients with obsessive-compulsive disorder American Journal of Psychiatry. 148: 1552-1557. PMID 1928472 DOI: 10.1176/Ajp.148.11.1552 |
0.134 |
|
1999 |
McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology. 147: 56-65. PMID 10591869 DOI: 10.1007/S002130051142 |
0.134 |
|
1992 |
Bagdy G, Sved AF, Murphy DL, Szemeredi K. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. European Journal of Pharmacology. 210: 285-9. PMID 1535317 DOI: 10.1016/0014-2999(92)90417-3 |
0.134 |
|
2005 |
Esaki T, Cook M, Shimoji K, Murphy DL, Sokoloff L, Holmes A. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proceedings of the National Academy of Sciences of the United States of America. 102: 5582-7. PMID 15809439 DOI: 10.1073/Pnas.0501509102 |
0.134 |
|
1987 |
Tariot PN, Cohen RM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL. L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Archives of General Psychiatry. 44: 427-33. PMID 3107514 DOI: 10.1001/Archpsyc.1987.01800170041007 |
0.134 |
|
1982 |
Pickar D, Murphy DL, Cohen RM, Campbell IC, Lipper S. Selective and Nonselective Monoamine Oxidase Inhibitors: Behavioral Disturbances During Their Administration to Depressed Patients Archives of General Psychiatry. 39: 535-540. PMID 7092487 DOI: 10.1001/Archpsyc.1982.04290050023006 |
0.134 |
|
2013 |
Ozomaro U, Cai G, Kajiwara Y, Yoon S, Makarov V, Delorme R, Betancur C, Ruhrmann S, Falkai P, Grabe HJ, Maier W, Wagner M, Lennertz L, Moessner R, Murphy DL, et al. Characterization of SLITRK1 variation in obsessive-compulsive disorder. Plos One. 8: e70376. PMID 23990902 DOI: 10.1371/Journal.Pone.0070376 |
0.133 |
|
1973 |
Donnelly EF, Murphy DL. Primary affective disorder: delineation of a unipolar depressive subtype Psychological Reports. 32. PMID 4145089 DOI: 10.2466/Pr0.1973.32.3.744 |
0.133 |
|
1994 |
Aulakh CS, Hill JL, Murphy DL. Attenuation of clonidine-induced growth hormone release following chronic glucocorticoid and 5-hydroxytryptamine uptake-inhibiting antidepressant treatments. Neuroendocrinology. 59: 35-41. PMID 8145893 DOI: 10.1159/000126635 |
0.133 |
|
1983 |
Insel TR, Hamilton JA, Guttmacher LB, Murphy DL. D-amphetamine in obsessive-compulsive disorder. Psychopharmacology. 80: 231-5. PMID 6412267 DOI: 10.1007/Bf00436159 |
0.133 |
|
1999 |
Altemus M, Greenberg BD, Keuler D, Jacobson KR, Murphy DL. Open trial of flutamide for treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 60: 442-5. PMID 10453797 DOI: 10.4088/Jcp.V60N0704 |
0.133 |
|
2018 |
Delgado-Acevedo C, Estay SF, Radke A, Sengupta A, Escobar AP, Henríquez-Belmar F, Reyes C, Haro V, Utreras E, Sotomayor-Zárate R, Cho A, Wendland JR, Kulkarni AB, Holmes A, Murphy DL, et al. Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30622300 DOI: 10.1038/S41386-018-0302-7 |
0.133 |
|
1979 |
Lipper S, Murphy DL, Slater S, Buchsbaum MS. Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation. Psychopharmacology. 62: 123-8. PMID 111274 DOI: 10.1007/Bf00427124 |
0.132 |
|
1989 |
Lawlor BA, Sunderland T, Hill JL, Mellow AM, Molchan SE, Mueller EA, Jacobsen FM, Murphy DL. Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects. Psychiatry Research. 29: 1-10. PMID 2772095 DOI: 10.1016/0165-1781(89)90181-9 |
0.132 |
|
1976 |
Donnelly CH, Richelson E, Murphy DL. Properties of monoamine oxidase in mouse neuroblastoma N1E-115 cells. Biochemical Pharmacology. 25: 1639-43. PMID 942463 DOI: 10.1016/0006-2952(76)90476-7 |
0.132 |
|
1976 |
Henry GM, Buchsbaum M, Murphy DL. Intravenous L DOPA plus carbidopa in depressed patients: average evoked response, learning, and behavioral changes Psychosomatic Medicine. 38: 95-105. PMID 1273240 DOI: 10.1097/00006842-197603000-00003 |
0.132 |
|
2011 |
Moya PR, Fox MA, Jensen CL, Laporte JL, French HT, Wendland JR, Murphy DL. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. Bmc Pharmacology. 11: 3. PMID 21473759 DOI: 10.1186/1471-2210-11-3 |
0.132 |
|
1998 |
Corá-Locatelli G, Greenberg BD, Martin J, Murphy DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 59: 480-1. PMID 9771822 DOI: 10.4088/Jcp.V59N0907D |
0.132 |
|
1981 |
Eisler T, Teräväinen H, Nelson R, Krebs H, Weise V, Lake CR, Ebert MH, Whetzel N, Murphy DL, Kopin IJ, Calne DB. Deprenyl in Parkinson disease. Neurology. 31: 19-23. PMID 6161320 DOI: 10.1212/Wnl.31.1.19 |
0.132 |
|
1973 |
Lott IT, Chase TN, Murphy DL. Down's syndrome: transport, storage, and metabolism of serotonin in blood platelets. Pediatric Research. 6: 730-5. PMID 4264688 DOI: 10.1203/00006450-197209000-00006 |
0.132 |
|
2006 |
Samuels JF, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Pinto A, Knowles JA, Piacentini J, Cannistraro PA, Cullen B, Bienvenu OJ, Rasmussen SA, et al. The OCD collaborative genetics study: methods and sample description. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 201-7. PMID 16511842 DOI: 10.1002/Ajmg.B.30224 |
0.132 |
|
1979 |
Pickar D, Cohen RM, Murphy DL, Fried D. Tyramine infusions in dipolar illness: Behavioral effects and longitudinal changes in pressor sensitivity American Journal of Psychiatry. 136: 1460-1463. PMID 495801 |
0.132 |
|
2001 |
Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, De Maeyer E, Murphy DL, Mossner R, Lesch KP, Hen R, Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 884-96. PMID 11157075 |
0.132 |
|
2009 |
Fox MA, Jensen CL, Murphy DL. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 1055-65. PMID 19275775 DOI: 10.1017/S146114570900011X |
0.132 |
|
1984 |
Aloi JA, Insel TR, Mueller EA, Murphy DL. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sciences. 34: 1325-31. PMID 6708733 DOI: 10.1016/0024-3205(84)90003-1 |
0.132 |
|
1980 |
Murphy DL, Kalin NH. Biological and behavioral consequences of alterations in monoamine oxidase activity. Schizophrenia Bulletin. 6: 355-67. PMID 6103577 DOI: 10.1093/Schbul/6.2.355 |
0.132 |
|
2009 |
Basselin M, Fox MA, Chang L, Bell JM, Greenstein D, Chen M, Murphy DL, Rapoport SI. Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1695-709. PMID 19145225 DOI: 10.1038/Npp.2008.227 |
0.131 |
|
1984 |
Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsibility in depression Life Sciences. 34: 1029-1039. PMID 6700367 DOI: 10.1016/0024-3205(84)90016-X |
0.131 |
|
2006 |
Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, Daws LC, Holmes A. Ethanol-related behaviors in serotonin transporter knockout mice. Alcoholism, Clinical and Experimental Research. 30: 1957-65. PMID 17117959 DOI: 10.1111/J.1530-0277.2006.00241.X |
0.131 |
|
1989 |
Wozniak KM, Aulakh CS, Hill JL, Murphy DL. Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology. 97: 269-74. PMID 2498937 DOI: 10.1007/Bf00442262 |
0.131 |
|
1978 |
Costa JL, Murphy DL, Reveille J. Evaluation of the uptake of various amines into storage vesicles of intact human platelets. British Journal of Pharmacology. 61: 223-8. PMID 922252 DOI: 10.1111/J.1476-5381.1977.Tb08408.X |
0.131 |
|
1983 |
Lake R, Pickar D, Zeigler M, Lipper S, Slater S, Murphy D. High plasma norepinephrine levels in patients with major affective disorder Journal of Clinical Psychopharmacology. 3: 118. DOI: 10.1097/00004714-198304000-00028 |
0.13 |
|
1979 |
Raymond Lake C, Coleman MD, Ziegler MG, Murphy DL. Fenfluramine and its effects on the sympathetic nervous system in man Current Medical Research and Opinion. 6: 63-72. DOI: 10.1185/03007997909117492 |
0.13 |
|
1991 |
Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder Biological Psychiatry. 29: 418-426. PMID 2018816 DOI: 10.1016/0006-3223(91)90264-M |
0.13 |
|
1993 |
Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Research. Molecular Brain Research. 17: 31-5. PMID 8381906 DOI: 10.1016/0169-328X(93)90069-2 |
0.13 |
|
1997 |
Aulakh CS, Mazzola-Pomietto P, Murphy DL. Long-term antidepressant treatment restores clonidine's effect on growth hormone secretion in a genetic animal model of depression. Pharmacology, Biochemistry, and Behavior. 55: 265-8. PMID 8951963 DOI: 10.1016/S0091-3057(96)00080-9 |
0.13 |
|
2009 |
Nestadt G, Di CZ, Riddle MA, Grados MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen B, Pinto A, Knowles JA, Piacentini J, Pauls DL, et al. Obsessive-compulsive disorder: subclassification based on co-morbidity. Psychological Medicine. 39: 1491-501. PMID 19046474 DOI: 10.1017/S0033291708004753 |
0.13 |
|
2007 |
Fox MA, Jensen CL, Gallagher PS, Murphy DL. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology. 53: 643-56. PMID 17765930 DOI: 10.1016/J.Neuropharm.2007.07.009 |
0.13 |
|
2010 |
Voon V, Butler TR, Ekanayake V, Gallea C, Ameli R, Murphy DL, Hallett M. Psychiatric symptoms associated with focal hand dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2249-52. PMID 20737548 DOI: 10.1002/Mds.23250 |
0.13 |
|
2012 |
Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, Cullen BA, Riddle MA, Greenberg BD, Rasmussen SA, Fyer AJ, Pinto A, Rauch SL, Pauls DL, McCracken JT, ... ... Murphy DL, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychological Medicine. 42: 1-13. PMID 21733222 DOI: 10.1017/S0033291711000742 |
0.129 |
|
2003 |
Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. Journal of Neuroscience Research. 71: 701-9. PMID 12584728 DOI: 10.1002/Jnr.10521 |
0.129 |
|
1974 |
Rapoport J, Quinn P, Scribanu N, Murphy DL. Platelet serotonin of hyperactive school age boys. The British Journal of Psychiatry : the Journal of Mental Science. 125: 138-40. PMID 4606916 DOI: 10.1192/Bjp.125.2.138 |
0.129 |
|
1994 |
Lesch KP, Gross J, Wolozin BL, Franzek E, Bengel D, Riederer P, Murphy DL. Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness Psychiatric Genetics. 4: 153-160. PMID 7719701 DOI: 10.1097/00041444-199400430-00005 |
0.129 |
|
2006 |
Adamec R, Burton P, Blundell J, Murphy DL, Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behavioural Brain Research. 170: 126-40. PMID 16546269 DOI: 10.1016/J.Bbr.2006.02.012 |
0.129 |
|
1972 |
Goodwin FK, Murphy DL, Dunner DL, Bunney WE. Lithium response in unipolar versus bipolar depression. The American Journal of Psychiatry. 129: 44-7. PMID 4556087 DOI: 10.1176/Ajp.129.1.44 |
0.129 |
|
1985 |
Garrick NA, Seppala T, Linnoila M, Murphy DL. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey. European Journal of Pharmacology. 110: 1-9. PMID 2408906 DOI: 10.1016/0014-2999(85)90022-6 |
0.129 |
|
1982 |
Potter WZ, Murphy DL, Wehr TA, Linnoila M, Goodwin FK. Clorgyline. A new treatment for patients with refractory rapid-cycling disorder. Archives of General Psychiatry. 39: 505-10. PMID 6807254 DOI: 10.1001/Archpsyc.1982.04290050001001 |
0.128 |
|
2012 |
Murphy DL. An overview of serotonin neurochemistry and neuroanatomy 5-Hydroxytryptamine in Psychiatry: a Spectrum of Ideas. DOI: 10.1093/acprof:oso/9780192620118.003.0003 |
0.128 |
|
1974 |
Murphy DL, Belmaker R, Wyatt RJ. Monamine oxidase in schizophrenia and other behavioral disorders. Journal of Psychiatric Research. 11: 221-47. PMID 4461792 DOI: 10.1016/0022-3956(74)90097-1 |
0.128 |
|
1977 |
Weingartner H, Miller H, Murphy DL. Mood-state-dependent retrieval of verbal associations. Journal of Abnormal Psychology. 86: 276-84. PMID 874186 DOI: 10.1037//0021-843X.86.3.276 |
0.128 |
|
1995 |
Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biological Psychiatry. 37: 740-9. PMID 7640329 DOI: 10.1016/0006-3223(94)00208-K |
0.128 |
|
1971 |
Beigel A, Murphy DL. Unipolar and bipolar affective illness. Differences in clinical characteristics accompanying depression. Archives of General Psychiatry. 24: 215-20. PMID 5100617 DOI: 10.1001/Archpsyc.1971.01750090021003 |
0.128 |
|
1984 |
Garrick NA, Scheinin M, Chang WH, Linnoila M, Murphy DL. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys. Biochemical Pharmacology. 33: 1423-7. PMID 6203542 DOI: 10.1016/0006-2952(84)90408-8 |
0.128 |
|
1970 |
Murphy DL, Colburn RW, Davis JM, Bunney WE. Imipramine and lithium effects of biogenic amine transport in depressed and manic-depressed patients. The American Journal of Psychiatry. 127: 339-45. PMID 5458598 DOI: 10.1176/Ajp.127.3.339 |
0.128 |
|
1985 |
Pons L, Nurnberger JI, Murphy DL. Mood-independent aberrancies in associative processes in bipolar affective disorder: an apparent stabilizing effect of lithium. Psychiatry Research. 14: 315-22. PMID 3860884 DOI: 10.1016/0165-1781(85)90099-X |
0.128 |
|
1977 |
Murphy DL, Belmaker RH, Buchsbaum M, Martin NF, Ciaranello R, Wyatt RJ. Biogenic amine related enzymes and personality variations in normals Psychological Medicine. 7: 149-157. PMID 870927 DOI: 10.1017/S0033291700023229 |
0.128 |
|
2007 |
Cromer KR, Schmidt NB, Murphy DL. Do traumatic events influence the clinical expression of compulsive hoarding? Behaviour Research and Therapy. 45: 2581-92. PMID 17673166 DOI: 10.1016/J.Brat.2007.06.005 |
0.128 |
|
1972 |
Murphy DL. Amine precursors, amines, and false neurotransmitters in depressed patients. The American Journal of Psychiatry. 129: 141-8. PMID 4339314 DOI: 10.1176/Ajp.129.2.141 |
0.128 |
|
1978 |
van Kammen DP, Murphy DL. Prediction of imipramine antidepressant response by a one-day dextro-amphetamine trial. The American Journal of Psychiatry. 135: 1179-84. PMID 358845 DOI: 10.1176/AJP.135.10.1179 |
0.128 |
|
2006 |
Ren-Patterson RF, Cochran LW, Holmes A, Lesch KP, Lu B, Murphy DL. Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cellular and Molecular Neurobiology. 26: 755-80. PMID 17029036 DOI: 10.1007/S10571-006-9048-6 |
0.127 |
|
1997 |
Bengel D, Heils A, Petri S, Seemann M, Glatz K, Andrews A, Murphy DL, Lesch KP. Gene structure and 5'-flanking regulatory region of the murine serotonin transporter. Brain Research. Molecular Brain Research. 44: 286-92. PMID 9073170 DOI: 10.1016/S0169-328X(96)00234-3 |
0.127 |
|
1977 |
Murphy DL, Brand E, Goldman T, Baker M, Wright C, van Kammen D, Gordon E. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment. The Journal of Nervous and Mental Disease. 164: 129-34. PMID 836485 DOI: 10.1097/00005053-197702000-00008 |
0.127 |
|
1972 |
Murphy DL, Goodwin FK, Bunney WE. A Reevaluation of Biogenic Amines in Manic and Depressive States Hospital Practice. 7: 85-92. DOI: 10.1080/21548331.1972.11706305 |
0.127 |
|
1990 |
Murphy DL, Sims KB, Karoum F, Chapelle Adl, Norio R, Sankila E-, Breakefield XO. Marked Amine and Amine Metabolite Changes in Norrie Disease Patients with an X‐Chromosomal Deletion Affecting Monoamine Oxidase Journal of Neurochemistry. 54: 242-247. PMID 2293615 DOI: 10.1111/J.1471-4159.1990.Tb13307.X |
0.127 |
|
1991 |
Bihari K, Pato MT, Hill JL, Murphy DL. Neurologic soft signs in obsessive-compulsive disorder. Archives of General Psychiatry. 48: 278-9. PMID 2036127 DOI: 10.1001/Archpsyc.1991.01810270090013 |
0.127 |
|
1998 |
Greenberg BD, McMahon FJ, Murphy DL. Serotonin transporter candidate gene studies in affective disorders and personality: promises and potential pitfalls. Molecular Psychiatry. 3: 186-9. PMID 9672885 DOI: 10.1038/Sj.Mp.4000415 |
0.127 |
|
2008 |
Kalueff AV, Ren-Patterson RF, LaPorte JL, Murphy DL. Domain interplay concept in animal models of neuropsychiatric disorders: a new strategy for high-throughput neurophenotyping research. Behavioural Brain Research. 188: 243-9. PMID 18164476 DOI: 10.1016/J.Bbr.2007.11.011 |
0.127 |
|
1978 |
Costa JL, Murphy DL, Smith MA, Pettigrew KD. Effects of antimycin A plus 2-deoxyglucose on uptake and vesicular storage of serotonin in human platelets. Life Sciences. 22: 1811-6. PMID 672429 DOI: 10.1016/0024-3205(78)90597-0 |
0.126 |
|
1969 |
Goodwin FK, Murphy DL, Bunney WE. Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Archives of General Psychiatry. 21: 486-96. PMID 4896983 DOI: 10.1001/Archpsyc.1969.01740220102012 |
0.126 |
|
1989 |
Bagdy G, Szemeredi K, Hill JL, Murphy DL. The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat. Neuropharmacology. 27: 975-80. PMID 3237317 DOI: 10.1016/0028-3908(88)90055-X |
0.126 |
|
1972 |
Murphy DL, Wyatt RJ. Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature. 238: 225-6. PMID 4558353 DOI: 10.1038/238225A0 |
0.126 |
|
1984 |
Murphy DL, Mueller EA, Insel T, Siever LJ, Aulakh C, Cohen RM. BIOLOGIC MARKERS FOR SEROTONERGIC DYSFUNCTION IN PSYCHIATRIC DISORDERS Clinical Neuropharmacology. 7: S154. DOI: 10.1097/00002826-198406001-00142 |
0.126 |
|
1979 |
Campbell IC, Robinson DS, Lovenberg W, Murphy DL. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. Journal of Neurochemistry. 32: 49-55. PMID 32233 DOI: 10.1111/J.1471-4159.1979.Tb04508.X |
0.126 |
|
1985 |
Cohen RM, Aulakh C, McLellan C, Murphy DL. 6-Hydroxydopamine pretreatment effects on alpha- and beta-adrenergic receptor adaptation to clorgyline. Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 158-61. PMID 2989714 DOI: 10.1007/Bf00501206 |
0.126 |
|
1975 |
Murphy DL, Cahan DH, Molinoff PB. Occurrence, transport, and storage of octopamine in human thrombocytes. Clinical Pharmacology and Therapeutics. 18: 587-93. PMID 1102236 |
0.126 |
|
1986 |
Murphy DL, Tamarkin L, Sunderland T, Garrick NA, Cohen RM. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl. Psychiatry Research. 17: 119-27. PMID 3008207 DOI: 10.1016/0165-1781(86)90067-3 |
0.126 |
|
1991 |
Pigott TA, Murphy DL. Are Effective Antiobsessional Drugs Interchangeable?-Reply Archives of General Psychiatry. 48: 858-859. DOI: 10.1001/Archpsyc.1991.01810330082014 |
0.126 |
|
1988 |
Newhouse PA, Sunderland T, Tariot PN, Weingartner H, Thompson K, Mellow AM, Cohen RM, Murphy DL. The effects of acute scopolamine in geriatric depression. Archives of General Psychiatry. 45: 906-12. PMID 3048225 DOI: 10.1001/Archpsyc.1988.01800340028004 |
0.126 |
|
2005 |
Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, Lesch KP, Lu B, Murphy DL. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. Journal of Neuroscience Research. 79: 756-71. PMID 15672416 DOI: 10.1002/Jnr.20410 |
0.125 |
|
1981 |
Cohen RM, Campbell IC, Cohen MR, Torda T, Pickar D, Siever LJ, Murphy DL. Presynaptic noradrenergic regulation during depression and antidepressant drug treatment. Psychiatry Research. 3: 93-105. PMID 7003637 DOI: 10.1016/0165-1781(80)90051-7 |
0.125 |
|
1979 |
Campbell IC, Shiling DJ, Lipper S, Slater S, Murphy DL. A biochemical measure of monoamine oxidase type A and B inhibitor effects in man. Journal of Psychiatric Research. 15: 77-84. PMID 490428 DOI: 10.1016/0022-3956(79)90020-7 |
0.125 |
|
1980 |
Donnelly EF, Waldman IN, Murphy DL, Wyatt RJ, Goodwin FK. Primary affective disorder: thought disorder in depression. Journal of Abnormal Psychology. 89: 315-9. PMID 7410698 DOI: 10.1037//0021-843X.89.3.315 |
0.125 |
|
1995 |
Little JT, Broocks A, Martin A, Hill JL, Tune LE, Mack C, Cantillon M, Molchan S, Murphy DL, Sunderland T. Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans. Psychopharmacology. 120: 280-8. PMID 8524975 DOI: 10.1007/Bf02311175 |
0.125 |
|
1988 |
Szele FG, Murphy DL, Garrick NA. Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates. Life Sciences. 43: 1297-303. PMID 3172981 DOI: 10.1016/0024-3205(88)90584-X |
0.125 |
|
2007 |
Goes FS, Zandi PP, Miao K, McMahon FJ, Steele J, Willour VL, Mackinnon DF, Mondimore FM, Schweizer B, Nurnberger JI, Rice JP, Scheftner W, Coryell W, Berrettini WH, Kelsoe JR, ... ... Murphy DL, et al. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. The American Journal of Psychiatry. 164: 236-47. PMID 17267786 DOI: 10.1176/Ajp.2007.164.2.236 |
0.125 |
|
1993 |
Aulakh CS, Hill JL, Murphy DL. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats. Neuroendocrinology. 57: 869-74. PMID 8413823 DOI: 10.1159/000126447 |
0.125 |
|
2011 |
Mroczkowski MM, Goes FS, Riddle MA, Grados MA, Bienvenu OJ, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Knowles JA, Piacentini J, Cullen B, Rasmussen SA, Geller DA, et al. Separation anxiety disorder in OCD. Depression and Anxiety. 28: 256-62. PMID 21308883 DOI: 10.1002/Da.20773 |
0.124 |
|
2007 |
Cromer KR, Schmidt NB, Murphy DL. An investigation of traumatic life events and obsessive-compulsive disorder. Behaviour Research and Therapy. 45: 1683-91. PMID 17067548 DOI: 10.1016/J.Brat.2006.08.018 |
0.124 |
|
1997 |
Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proceedings of the National Academy of Sciences of the United States of America. 94: 4572-5. PMID 9114031 DOI: 10.1073/Pnas.94.9.4572 |
0.124 |
|
1987 |
Murphy DL, Fuller RW, Naranjo CA, Sellers EM, ??rsberg M, Eriksson B, M??Rrtensson B, Tr??Uskman-Bendz L, Wcagner A. Serotonin neurochemistry and psychopharmacology in 1986 Journal of Clinical Psychopharmacology. 7: 48. DOI: 10.1097/00004714-198702000-00019 |
0.124 |
|
1977 |
Costa JL, Silber SA, Murphy DL. Effects of reserpine and imipramine on vesicular serotonin uptake and storage in intact human platelets. Life Sciences. 21: 181-8. PMID 886915 DOI: 10.1016/0024-3205(77)90300-9 |
0.124 |
|
2000 |
Greenberg BD, Murphy DL, Rasmussen SA. Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. The Psychiatric Clinics of North America. 23: 671-86, xii. PMID 10986735 DOI: 10.1016/S0193-953X(05)70188-X |
0.124 |
|
2007 |
Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behavioural Brain Research. 179: 1-18. PMID 17306892 DOI: 10.1016/J.Bbr.2007.01.023 |
0.124 |
|
2008 |
Laporte JL, Ren-Patterson RF, Murphy DL, Kalueff AV. Refining psychiatric genetics: from 'mouse psychiatry' to understanding complex human disorders. Behavioural Pharmacology. 19: 377-84. PMID 18690099 DOI: 10.1097/Fbp.0B013E32830Dc09B |
0.124 |
|
2013 |
Moya PR, Wendland JR, Rubenstein LM, Timpano KR, Heiman GA, Tischfield JA, King RA, Andrews AM, Ramamoorthy S, McMahon FJ, Murphy DL. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1263-70. PMID 23630162 DOI: 10.1002/Mds.25460 |
0.124 |
|
2005 |
Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, Greenberg BD, Murphy DL. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Research. 135: 121-32. PMID 15893825 DOI: 10.1016/J.Psychres.2005.03.003 |
0.124 |
|
2005 |
Ni W, Wilhelm CS, Bader M, Murphy DL, Lookingland K, Watts SW. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 314: 953-60. PMID 15901794 DOI: 10.1124/Jpet.105.087080 |
0.124 |
|
2004 |
Tjurmina OA, Armando I, Saavedra JM, Li Q, Murphy DL. Life-long serotonin reuptake deficiency results in complex alterations in adrenomedullary responses to stress. Annals of the New York Academy of Sciences. 1018: 99-104. PMID 15240357 DOI: 10.1196/Annals.1296.011 |
0.124 |
|
1987 |
Sunderland T, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease. Psychopharmacology. 91: 293-6. PMID 2436247 DOI: 10.1007/Bf00518180 |
0.124 |
|
1977 |
Lake CR, Ziegler MG, Murphy DL. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Archives of General Psychiatry. 34: 553-6. PMID 558741 DOI: 10.1001/Archpsyc.1977.01770170063005 |
0.124 |
|
1972 |
Bunney WE, Goodwin FK, Murphy DL, House KM, Gordon EK. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Archives of General Psychiatry. 27: 304-9. PMID 4340658 DOI: 10.1001/Archpsyc.1972.01750270014002 |
0.123 |
|
2009 |
Timpano KR, Buckner JD, Richey JA, Murphy DL, Schmidt NB. Exploration of anxiety sensitivity and distress tolerance as vulnerability factors for hoarding behaviors. Depression and Anxiety. 26: 343-53. PMID 19123454 DOI: 10.1002/Da.20469 |
0.123 |
|
1993 |
Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter Journal of Neurochemistry. 60: 2319-2322. PMID 7684072 DOI: 10.1111/J.1471-4159.1993.Tb03522.X |
0.123 |
|
1999 |
Ben-Zion IZ, Meiri G, Greenberg BD, Murphy DL, Benjamin J. Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline. The American Journal of Psychiatry. 156: 1635-7. PMID 10518177 DOI: 10.1176/Ajp.156.10.1635 |
0.123 |
|
1974 |
Carlson HE, Robbins J, Murphy DL. The effects of lithium on thyroid iodine release in patients with primary affective disorder. Psychopharmacologia. 35: 249-56. PMID 4829324 DOI: 10.1007/Bf00437754 |
0.123 |
|
1985 |
Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Ismond D. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Archives of General Psychiatry. 42: 962-6. PMID 3899047 DOI: 10.1001/Archpsyc.1985.01790330042005 |
0.123 |
|
1972 |
Dunner DL, Goodwin FK, Gershon ES, Murphy DL, Bunney WE. Excretion of 17-OHCS in unipolar and bipolar depressed patients. Archives of General Psychiatry. 26: 360-3. PMID 5013521 DOI: 10.1001/Archpsyc.1972.01750220070013 |
0.123 |
|
2003 |
Montañez S, Owens WA, Gould GG, Murphy DL, Daws LC. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. Journal of Neurochemistry. 86: 210-9. PMID 12807440 DOI: 10.1046/J.1471-4159.2003.01836.X |
0.123 |
|
1992 |
Lesch KP, Aulakh CS, Murphy DL. 5-HT1A receptor sensitivity in depression and anxiety disorders: molecular mechanisms of neuroadaption. Clinical Neuropharmacology. 208A-209A. PMID 1498813 DOI: 10.1097/00002826-199201001-00109 |
0.123 |
|
1976 |
Belmaker RH, Ebstein R, Rimon R, Wyatt RJ, Murphy DL. Electrophoresis of platelet monoamine oxidase in schizophrenia and manic-depressive illness. Acta Psychiatrica Scandinavica. 54: 67-72. PMID 952234 DOI: 10.1111/j.1600-0447.1976.tb00094.x |
0.123 |
|
1977 |
Buchsbaum MS, Haier RJ, Murphy DL. Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta Psychiatrica Scandinavica. 56: 69-79. PMID 331876 DOI: 10.1111/J.1600-0447.1977.Tb06665.X |
0.123 |
|
1984 |
Zahn TP, Insel TR, Murphy DL. Psychophysiological changes during pharmacological treatment of patients with obsessive compulsive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 145: 39-44. PMID 6378303 DOI: 10.1192/Bjp.145.1.39 |
0.123 |
|
2017 |
Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, McLaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, McCracken JT, Piacentini J, ... ... Murphy DL, et al. Self-reported executive function and hoarding in adults with obsessive-compulsive disorder. Comprehensive Psychiatry. 81: 53-59. PMID 29268152 DOI: 10.1016/J.Comppsych.2017.11.009 |
0.123 |
|
1991 |
Aulakh CS, Zohar J, Wozniak KM, Hill JL, Haass M, Murphy DL. Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats. Pharmacology, Biochemistry, and Behavior. 39: 91-5. PMID 1924518 DOI: 10.1016/0091-3057(91)90402-N |
0.123 |
|
1977 |
de la Vega CE, Slater S, Ziegler MG, Lake CR, Murphy DL. Reduction in plasma norepinephrine during fenfluramine treatment. Clinical Pharmacology and Therapeutics. 21: 216-21. PMID 319936 DOI: 10.1002/Cpt1977212216 |
0.122 |
|
1999 |
Hamer DH, Greenberg BD, Sabol SZ, Murphy DL. Role of the serotonin transporter gene in temperament and character. Journal of Personality Disorders. 13: 312-27. PMID 10633313 DOI: 10.1521/Pedi.1999.13.4.312 |
0.122 |
|
2007 |
Kalueff AV, Fox MA, Gallagher PS, Murphy DL. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior. 6: 389-400. PMID 16939636 DOI: 10.1111/J.1601-183X.2006.00270.X |
0.122 |
|
1980 |
Lerner P, Major LF, Dendel PS, Campbell IC, Murphy DL. Central and peripheral dopamine beta hydroxylase: responses to long term treatment with monoamine oxidase inhibitors. Neuropharmacology. 19: 877-81. PMID 7422098 DOI: 10.1016/0028-3908(80)90087-8 |
0.122 |
|
1982 |
Cohen RM, Ebstein RP, Daly JW, Murphy DL. Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 2: 1588-95. PMID 6292376 |
0.122 |
|
1977 |
Buchsbaum MS, van Kammen DP, Murphy DL. Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients. Psychopharmacology. 51: 129-35. PMID 402663 DOI: 10.1007/Bf00431728 |
0.122 |
|
1993 |
Lesch KP, Aulakh CS, Murphy DL. Brain serotonin subsystem complexity and receptor heterogeneity: therapeutic potential of selective serotonin agonists and antagonists. Psychopharmacology Series. 10: 52-69. PMID 8361982 DOI: 10.1007/978-3-642-78010-3_6 |
0.122 |
|
1976 |
Wyatt RJ, Murphy DL. Low platelet monoamine oxidase activity and schizophrenia. Schizophrenia Bulletin. 2: 77-89. PMID 779021 DOI: 10.1093/Schbul/2.1.77 |
0.122 |
|
1998 |
Broocks A, Little JT, Martin A, Minichiello MD, Dubbert B, Mack C, Tune L, Murphy DL, Sunderland T. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. Biological Psychiatry. 43: 408-16. PMID 9532345 DOI: 10.1016/S0006-3223(97)00388-0 |
0.121 |
|
1989 |
Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study. Archives of General Psychiatry. 46: 542-9. PMID 2730278 DOI: 10.1001/Archpsyc.1989.01810060064010 |
0.121 |
|
1983 |
Siever LJ, Kafka MS, Insel TR, Lake CR, Murphy DL. Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responses. Psychiatry Research. 9: 37-44. PMID 6310663 DOI: 10.1016/0165-1781(83)90087-2 |
0.121 |
|
1988 |
Wozniak KM, Aulakh CS, Hill JL, Murphy DL. The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacology, Biochemistry, and Behavior. 30: 451-6. PMID 2971978 DOI: 10.1016/0091-3057(88)90479-0 |
0.121 |
|
1992 |
Lesch KP, Aulakh CS, Wolozin BL, Murphy DL. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression Pharmacology & Toxicology. 71: 49-60. PMID 1480560 DOI: 10.1111/J.1600-0773.1992.Tb01629.X |
0.121 |
|
2008 |
Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology. Nature Reviews. Neuroscience. 9: 85-96. PMID 18209729 DOI: 10.1038/Nrn2284 |
0.121 |
|
1977 |
Costa JL, Murphy DL, Kafka MS. Demonstration and evaluation of apparent cytoplasmic and vesicular serotonin compartments in human platelets. Biochemical Pharmacology. 26: 517-21. PMID 849349 DOI: 10.1016/0006-2952(77)90327-6 |
0.121 |
|
2001 |
Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I, Arellano J, DeFelipe J, Gimenez-Amaya JM, Conciatori M, Marino R, Baldi A, Cabib S, Pascucci T, Uhl GR, ... Murphy DL, et al. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 6862-73. PMID 11517274 DOI: 10.1523/Jneurosci.21-17-06862.2001 |
0.121 |
|
2006 |
Kalueff AV, Gallagher PS, Murphy DL. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. Neuroreport. 17: 1347-51. PMID 16951583 DOI: 10.1097/01.Wnr.0000230514.08962.76 |
0.121 |
|
1982 |
Costa JL, Murphy DL, Stark H. Applicability of models for carrier-mediated serotonin transport to pools of serotonin in intact human platelets. The Journal of Physiology. 316: 153-61. PMID 7320861 DOI: 10.1113/Jphysiol.1981.Sp013779 |
0.121 |
|
2011 |
Hagino Y, Takamatsu Y, Yamamoto H, Iwamura T, Murphy DL, Uhl GR, Sora I, Ikeda K. Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters. Current Neuropharmacology. 9: 91-5. PMID 21886569 DOI: 10.2174/157015911795017254 |
0.121 |
|
2008 |
Ross J, Berrettini W, Coryell W, Gershon ES, Badner JA, Kelsoe JR, McInnis MG, McMahon FJ, Murphy DL, Nurnberger JI, Foroud T, Rice JP, Scheftner WB, Zandi P, Edenberg H, et al. Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20. Psychiatric Genetics. 18: 191-8. PMID 18628681 DOI: 10.1097/Ypg.0B013E3283050Aa5 |
0.121 |
|
2007 |
Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 684-91. PMID 17234600 DOI: 10.1523/Jneurosci.4595-06.2007 |
0.121 |
|
2004 |
Li Q, Holmes A, Ma L, Van de Kar LD, Garcia F, Murphy DL. Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10868-77. PMID 15574737 DOI: 10.1523/Jneurosci.3223-04.2004 |
0.12 |
|
1986 |
TARIOT PN, MURPHY DL, SUNDERLAND T, MUELLER EA, COHEN RM. Rapid Antidepressant Effect of Addition of Lithium Journal of Clinical Psychopharmacology. 6: 165???166. DOI: 10.1097/00004714-198606000-00008 |
0.12 |
|
1989 |
Brewerton T, Murphy D, Jimerson DC. A comparison of neuroendocrine responses to L-TRP and m-CPP in bulimics and controls Biological Psychiatry. 25: A19. DOI: 10.1016/0006-3223(89)91524-2 |
0.12 |
|
1994 |
Aulakh CS, Hill JL, Murphy DL. Enhanced anorexic responses to m-chlorophenylpiperazine during lithium administration to fawn-hooded rats. Pharmacology, Biochemistry, and Behavior. 49: 759-62. PMID 7862734 DOI: 10.1016/0091-3057(94)90098-1 |
0.12 |
|
1989 |
Major LF, Lake CR, Lipper S, Lerner P, Murphy DL. The central noradrenergic system and affective response to MAO inhibitors. Progress in Neuro-Psychopharmacology. 3: 535-42. PMID 401004 DOI: 10.1016/0364-7722(79)90007-9 |
0.12 |
|
2012 |
Murphy DL. Smee. Radiology Management. 34: 6. PMID 23270115 |
0.12 |
|
2012 |
Murphy DL. Go! Go! Go! Radiology Management. 34: 6. PMID 22720533 |
0.12 |
|
2012 |
Murphy DL. Serotonin neurochemistry: A commentary on some of its quandaries. Neurochemistry International. 8: 161-3. PMID 20493042 DOI: 10.1016/0197-0186(86)90159-2 |
0.119 |
|
2002 |
Liu MT, Rayport S, Jiang Y, Murphy DL, Gershon MD. Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. American Journal of Physiology. Gastrointestinal and Liver Physiology. 283: G1398-411. PMID 12388212 DOI: 10.1152/Ajpgi.00203.2002 |
0.119 |
|
2002 |
Holmes A, Murphy DL, Crawley JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology. 161: 160-7. PMID 11981596 DOI: 10.1007/S00213-002-1024-3 |
0.119 |
|
2010 |
Fox MA, Stein AR, French HT, Murphy DL. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). British Journal of Pharmacology. 159: 879-87. PMID 20128812 DOI: 10.1111/J.1476-5381.2009.00578.X |
0.119 |
|
1981 |
Insel TR, Murphy DL. The psychopharmacological treatment of obsessive-compulsive disorder: a review. Journal of Clinical Psychopharmacology. 1: 304-11. PMID 6174553 DOI: 10.1097/00004714-198109000-00006 |
0.119 |
|
1995 |
Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Hill JL, Murphy DL. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology. 117: 193-9. PMID 7753967 DOI: 10.1007/Bf02245187 |
0.119 |
|
1978 |
Schooler C, Zahn TP, Murphy DL, Buchsbaum MS. Psychological correlates of monoamine oxidase activity in normals. The Journal of Nervous and Mental Disease. 166: 177-86. PMID 641536 DOI: 10.1097/00005053-197803000-00003 |
0.119 |
|
1994 |
Aulakh CS, Hill JL, Murphy DL. Lithium treatment restores clonidine's effect in an animal model of depression. Pharmacology, Biochemistry, and Behavior. 47: 985-7. PMID 8029274 DOI: 10.1016/0091-3057(94)90308-5 |
0.119 |
|
1973 |
Murphy DL, Goodwin FK, Brodie HK, Bunney WE. L-dopa, dopamine, and hypomania. The American Journal of Psychiatry. 130: 79-82. PMID 4682751 DOI: 10.1176/Ajp.130.1.79 |
0.119 |
|
1989 |
Aulakh CS, Haass M, Zohar J, Wozniak KM, Hill JL, Murphy DL. Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats. Pharmacology, Biochemistry, and Behavior. 32: 37-42. PMID 2734349 DOI: 10.1016/0091-3057(89)90207-4 |
0.119 |
|
2006 |
Hasler G, Kazuba D, Murphy DL. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 403-8. PMID 16583440 DOI: 10.1002/Ajmg.B.30309 |
0.118 |
|
1978 |
Donnelly EF, Murphy DL, Goodwin FK. Primary affective disorder: anxiety in unipolar and bipolar depressed groups. Journal of Clinical Psychology. 34: 621-3. PMID 690197 DOI: 10.1002/1097-4679(197807)34:3<621::Aid-Jclp2270340307>3.0.Co;2-X |
0.118 |
|
2008 |
Cullen B, Samuels JF, Pinto A, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Greenberg BD, Knowles JA, Piacentini J, Bienvenu OJ, Grados MA, Riddle MA, Rasmussen SA, Pauls DL, et al. Demographic and clinical characteristics associated with treatment status in family members with obsessive-compulsive disorder. Depression and Anxiety. 25: 218-24. PMID 17345603 DOI: 10.1002/Da.20293 |
0.118 |
|
2009 |
Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z, Chen JJ, Murphy DL, Gershon MD. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology. 296: G685-95. PMID 19095763 DOI: 10.1152/Ajpgi.90685.2008 |
0.118 |
|
2002 |
Holmes A, Yang RJ, Murphy DL, Crawley JN. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 914-23. PMID 12464448 DOI: 10.1016/S0893-133X(02)00374-3 |
0.118 |
|
2003 |
Armando I, Tjurmina OA, Li Q, Murphy DL, Saavedra JM. The serotonin transporter is required for stress-evoked increases in adrenal catecholamine synthesis and angiotensin II AT(2) receptor expression. Neuroendocrinology. 78: 217-25. PMID 14583654 DOI: 10.1159/000073705 |
0.118 |
|
1988 |
Wang P, Aulakh CS, Hill JL, Murphy DL. Fawn hooded rats are subsensitive to the food intake suppressant effects of 5-HT agonists. Psychopharmacology. 94: 558-62. PMID 2967518 DOI: 10.1007/Bf00212855 |
0.117 |
|
2006 |
Daws LC, Montañez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6431-8. PMID 16775130 DOI: 10.1523/Jneurosci.4050-05.2006 |
0.117 |
|
1973 |
Henry GM, Weingartner H, Murphy DL. Influence of affective states and psychoactive drugs on verbal learning and memory. The American Journal of Psychiatry. 130: 966-71. PMID 4727774 DOI: 10.1176/Ajp.130.9.966 |
0.117 |
|
1981 |
Pickar D, Cohen RM, Jimerson DC, Murphy DL. Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity Psychopharmacology. 74: 4-7. PMID 6791202 DOI: 10.1007/Bf00431747 |
0.117 |
|
1984 |
Cohen RM, Aulakh CS, Murphy DL. Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine. European Journal of Pharmacology. 94: 175-9. PMID 6653658 DOI: 10.1016/0014-2999(83)90459-4 |
0.117 |
|
1989 |
Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB. Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain. 37: 223-7. PMID 2664664 DOI: 10.1016/0304-3959(89)90134-6 |
0.117 |
|
1983 |
Garrick NA, Murphy DL. Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin. Biochemical Pharmacology. 31: 4061-6. PMID 7159481 DOI: 10.1016/0006-2952(82)90656-6 |
0.117 |
|
2002 |
Zhou FC, Lesch KP, Murphy DL. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Research. 942: 109-19. PMID 12031859 DOI: 10.1016/S0006-8993(02)02709-9 |
0.117 |
|
1993 |
Martin A, Pigott TA, Lalonde FM, Dalton I, Dubbert B, Murphy DL. Lack of evidence for huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder Biological Psychiatry. 33: 345-353. PMID 8471692 DOI: 10.1016/0006-3223(93)90323-6 |
0.116 |
|
2008 |
Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR, Murphy DL. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Human Molecular Genetics. 17: 717-23. PMID 18055562 DOI: 10.1093/Hmg/Ddm343 |
0.116 |
|
1990 |
Bagdy G, Calogero AE, Szemeredi K, Gomez MT, Murphy DL, Chrousos GP, Gold PW. β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action Brain Research. 537: 227-232. PMID 2150776 DOI: 10.1016/0006-8993(90)90362-F |
0.116 |
|
1974 |
Belmaker RH, Murphy DL, Wyatt RJ, Loriaux DL. Human platelet monoamine oxidase changes during the menstrual cycle. Archives of General Psychiatry. 31: 553-6. PMID 4422238 DOI: 10.1001/Archpsyc.1974.01760160093019 |
0.116 |
|
1994 |
Brewerton TD, Murphy DL, Jimerson DC. Testmeal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 11: 63-71. PMID 7945745 DOI: 10.1038/Npp.1994.36 |
0.116 |
|
2007 |
Schmitt A, Benninghoff J, Moessner R, Rizzi M, Paizanis E, Doenitz C, Gross S, Hermann M, Gritti A, Lanfumey L, Fritzen S, Reif A, Hamon M, Murphy DL, Vescovi A, et al. Adult neurogenesis in serotonin transporter deficient mice. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1107-19. PMID 17510734 DOI: 10.1007/S00702-007-0724-6 |
0.116 |
|
1980 |
Donnelly EF, Murphy DL, Waldman IN. Denial and somatization as characteristics of bipolar depressed groups Journal of Clinical Psychology. 36: 159-162. PMID 7391231 DOI: 10.1002/1097-4679(198001)36:1<159::Aid-Jclp2270360116>3.0.Co;2-Y |
0.116 |
|
2000 |
Greenberg BD, Ziemann U, Corá-Locatelli G, Harmon A, Murphy DL, Keel JC, Wassermann EM. Altered cortical excitability in obsessive-compulsive disorder. Neurology. 54: 142-7. PMID 10636140 DOI: 10.1212/Wnl.54.1.142 |
0.115 |
|
2002 |
Roca CA, Schmidt PJ, Smith MJ, Danaceau MA, Murphy DL, Rubinow DR. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder. The American Journal of Psychiatry. 159: 1876-81. PMID 12411222 DOI: 10.1176/Appi.Ajp.159.11.1876 |
0.115 |
|
1981 |
Kalin NH, Risch SC, Janowsky DS, Murphy DL. Use of dexamethasone suppression test in clinical psychiatry. Journal of Clinical Psychopharmacology. 1: 64-9. PMID 7298885 DOI: 10.1097/00004714-198103000-00004 |
0.115 |
|
2010 |
Moya PR, Murphy DL, McMahon FJ, Wendland JR. Increased gene expression of diacylglycerol kinase η in bipolar disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1127-8. PMID 20519059 DOI: 10.1017/S1461145710000593 |
0.115 |
|
1983 |
Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Archives of General Psychiatry. 40: 613-9. PMID 6303264 DOI: 10.1001/Archpsyc.1983.04390010023003 |
0.115 |
|
1979 |
Lerner P, Major LF, Murphy DL, Lipper S, Lake CR, Lovenberg W. Dopamine-beta-hydroxylase and norepinephrine in human cerebrospinal fluid: effects of monoamine oxidase inhibitors. Neuropharmacology. 18: 423-6. PMID 450208 DOI: 10.1016/0028-3908(79)90152-7 |
0.115 |
|
2009 |
Bienvenu OJ, Wang Y, Shugart YY, Welch JM, Grados MA, Fyer AJ, Rauch SL, McCracken JT, Rasmussen SA, Murphy DL, Cullen B, Valle D, Hoehn-Saric R, Greenberg BD, Pinto A, et al. Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 710-20. PMID 19051237 DOI: 10.1002/Ajmg.B.30897 |
0.115 |
|
1985 |
Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment. Archives of General Psychiatry. 42: 969-73. PMID 2412521 DOI: 10.1001/Archpsyc.1985.01790330049006 |
0.115 |
|
1988 |
TARIOT PN, SUNDERLAND T, COHEN RM, NEWHOUSE PA, MUELLER EA, MURPHY DL. Tranylcypromine Compared with L-Deprenyl in Alzheimer??s Disease Journal of Clinical Psychopharmacology. 8: 23???27. DOI: 10.1097/00004714-198802000-00004 |
0.115 |
|
1996 |
Keuler DJ, Altemus M, Michelson D, Greenberg B, Murphy DL. Behavioral effects of naloxone infusion in obsessive-compulsive disorder. Biological Psychiatry. 40: 154-6. PMID 8793049 DOI: 10.1016/0006-3223(95)00632-X |
0.114 |
|
1981 |
Garrick NA, Murphy DL. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology. 72: 27-33. PMID 6781004 DOI: 10.1007/Bf00433804 |
0.114 |
|
2007 |
Grados MA, Samuels J, Shugart YY, Willour VL, Wang Y, Cullen B, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Wendland JR, Murphy DL, Nestadt G, Detera-Wadleigh S. Rare plus common SERT variants in obsessive-compulsive disorder. Molecular Psychiatry. 12: 422-3. PMID 17453059 DOI: 10.1038/Sj.Mp.4001970 |
0.114 |
|
2006 |
LaSalle-Ricci VH, Arnkoff DB, Glass CR, Crawley SA, Ronquillo JG, Murphy DL. The hoarding dimension of OCD: psychological comorbidity and the five-factor personality model. Behaviour Research and Therapy. 44: 1503-12. PMID 16386705 DOI: 10.1016/J.Brat.2005.11.009 |
0.114 |
|
1979 |
Kleinman JE, Potkin S, Rogol A, Buchsbaum MS, Murphy DL, Gillin JC, Nasrallah HA, Wyatt RJ. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science (New York, N.Y.). 206: 479-81. PMID 504993 DOI: 10.1126/Science.504993 |
0.114 |
|
1987 |
Murphy DL, Sunderland T, Garrick NA, Aulakh CS, Cohen RM. Selective amine oxidase inhibitors: basic to clinical studies and back. Psychopharmacology Series. 3: 135-46. PMID 3547393 DOI: 10.1007/978-3-642-71288-3_16 |
0.114 |
|
2005 |
Qu Y, Villacreses N, Murphy DL, Rapoport SI. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology. 180: 12-20. PMID 15834538 DOI: 10.1007/S00213-005-2231-5 |
0.114 |
|
1976 |
Redmond DE, Baulu J, Murphy DL, Loriaux DL, Zeigler MG, Lake CR. The effects of testosterone on plasma and platelet monoamine oxidase (MAO) an plasma dopamine-beta-hydroxylase (DBH) activities in the male rhesus monkey. Psychosomatic Medicine. 38: 315-26. PMID 824661 DOI: 10.1097/00006842-197609000-00004 |
0.114 |
|
1990 |
Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Archives of General Psychiatry. 47: 840-8. PMID 2393342 DOI: 10.1001/Archpsyc.1990.01810210048007 |
0.114 |
|
2007 |
Kalueff AV, Jensen CL, Murphy DL. Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Research. 1169: 87-97. PMID 17692295 DOI: 10.1016/J.Brainres.2007.07.009 |
0.114 |
|
2015 |
Mattheisen M, Samuels JF, Wang Y, Greenberg BD, Fyer AJ, McCracken JT, Geller DA, Murphy DL, Knowles JA, Grados MA, Riddle MA, Rasmussen SA, McLaughlin NC, Nurmi EL, Askland KD, et al. Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS. Molecular Psychiatry. 20: 337-44. PMID 24821223 DOI: 10.1038/mp.2014.43 |
0.114 |
|
1995 |
Martin A, Wiggs CL, Altemus M, Rubenstein C, Murphy DL. Working memory as assessed by subject-ordered tasks in patients with obsessive-compulsive disorder. Journal of Clinical and Experimental Neuropsychology. 17: 786-92. PMID 8557818 DOI: 10.1080/01688639508405167 |
0.114 |
|
1982 |
Siever LJ, Uhde TW, Murphy DL. Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Research. 6: 293-302. PMID 6287513 DOI: 10.1016/0165-1781(82)90019-1 |
0.113 |
|
1981 |
Zis AP, Gold PW, Paul SM, Goodwin FK, Murphy DL. Elevation of human plasma and platelet amine oxidase activity in response to intravenous dopamine. Life Sciences. 28: 371-6. PMID 7219052 DOI: 10.1016/0024-3205(81)90081-3 |
0.113 |
|
1971 |
Henry GM, Weingartner H, Murphy DL. Idiosyncratic patterns of learning and word association during mania. The American Journal of Psychiatry. 128: 564-74. PMID 5114371 DOI: 10.1176/Ajp.128.5.564 |
0.113 |
|
2007 |
Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, Holmes A. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behavior Genetics. 37: 214-22. PMID 17177116 DOI: 10.1007/S10519-006-9129-9 |
0.113 |
|
1972 |
Bunney WE, Goodwin FK, Murphy DL. The "switch process" in manic-depressive illness. 3. Theoretical implications. Archives of General Psychiatry. 27: 312-7. PMID 5051619 DOI: 10.1001/Archpsyc.1972.01750270022003 |
0.113 |
|
2015 |
Mroczkowski MM, Goes FS, Riddle MA, Grados MA, Bienvenu OJ, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Knowles JA, Piacentini J, Cullen B, Rasmussen SA, Pauls DL, et al. Dependent personality, separation anxiety disorder and other anxiety disorders in OCD. Personality and Mental Health. PMID 26542617 DOI: 10.1002/Pmh.1321 |
0.113 |
|
2010 |
Laporte JL, Ren-Patterson RF, Murphy DL, Kalueff AV. Modeling SERT × BDNF interactions in brain disorders: Single BDNF gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities in serotonin transporter knock-out mice Experimental Models in Serotonin Transporter Research. 270-287. DOI: 10.1017/CBO9780511729935.010 |
0.113 |
|
2017 |
Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, McLaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, Nestadt P, McCracken JT, ... ... Murphy DL, et al. An investigation of doubt in obsessive-compulsive disorder. Comprehensive Psychiatry. 75: 117-124. PMID 28359017 DOI: 10.1016/J.Comppsych.2017.03.004 |
0.113 |
|
1979 |
Costa JL, Pettigrew KD, Murphy DL. Electron probe microanalysis of changes in dense-body phosphorus and calcium content following alterations in platelet serotonin levels. Biochemical Pharmacology. 28: 23-6. PMID 758907 DOI: 10.1016/0006-2952(79)90264-8 |
0.113 |
|
1989 |
Bagdy G, Szemeredi K, Murphy DL. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats. The Journal of Pharmacy and Pharmacology. 41: 270-2. PMID 2568470 DOI: 10.1111/J.2042-7158.1989.Tb06450.X |
0.113 |
|
2003 |
Persico AM, Baldi A, Dell'Acqua ML, Moessner R, Murphy DL, Lesch KP, Keller F. Reduced programmed cell death in brains of serotonin transporter knockout mice. Neuroreport. 14: 341-4. PMID 12634480 DOI: 10.1097/00001756-200303030-00009 |
0.113 |
|
2003 |
Vogel C, Mössner R, Gerlach M, Heinemann T, Murphy DL, Riederer P, Lesch KP, Sommer C. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 708-15. PMID 12533631 DOI: 10.1523/Jneurosci.23-02-00708.2003 |
0.113 |
|
1996 |
Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genetics. 12: 81-4. PMID 8528258 DOI: 10.1038/Ng0196-81 |
0.113 |
|
1987 |
Murphy DL, Garrick NA, Hill JL, Tamarkin L. Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys. Psychopharmacology. 92: 382-7. PMID 3114792 DOI: 10.1007/Bf00210848 |
0.112 |
|
1972 |
Beigel A, Murphy DL. Assessing clinical characteristics of the manic state. The American Journal of Psychiatry. 128: 688-94. PMID 5147723 DOI: 10.1176/Ajp.128.6.688 |
0.112 |
|
2001 |
Enoch MA, Greenberg BD, Murphy DL, Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biological Psychiatry. 49: 385-8. PMID 11239910 DOI: 10.1016/S0006-3223(00)01040-4 |
0.112 |
|
1985 |
Campbell IC, Durcan MJ, Cohen RM, Pickar D, Chugani D, Murphy DL. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat Pharmacology, Biochemistry and Behavior. 23: 921-925. PMID 4080777 DOI: 10.1016/0091-3057(85)90093-0 |
0.112 |
|
1999 |
Schuback DE, Mulligan EL, Sims KB, Tivol EA, Greenberg BD, Chang SF, Yang SL, Mau YC, Shen CY, Ho MS, Yang NH, Butler MG, Fink S, Schwartz CE, Berlin F, ... ... Murphy DL, et al. Screen for MAOA mutations in target human groups. American Journal of Medical Genetics. 88: 25-8. PMID 10050962 DOI: 10.1002/(Sici)1096-8628(19990205)88:1<25::Aid-Ajmg4>3.0.Co;2-E |
0.112 |
|
1971 |
Murphy DL, Brodie HKH, Goodwin FK, Bunney WE. Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature. 229: 135-136. PMID 4321339 DOI: 10.1038/229135A0 |
0.112 |
|
2015 |
Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I. Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Behavioural Pharmacology. 26: 345-52. PMID 25794333 DOI: 10.1097/Fbp.0000000000000135 |
0.112 |
|
2008 |
Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, Coryell W, El-Mallakh R, Gershon ES, Kelsoe JR, Lawson WB, MacKinnon DF, McInnis M, McMahon FJ, Murphy DL, Rice J, et al. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatric Genetics. 18: 267-74. PMID 19018231 DOI: 10.1097/Ypg.0B013E3283060F59 |
0.112 |
|
1989 |
Aulakh CS, Wozniak KM, Hill JL, Devane CL, Tolliver TJ, Murphy DL. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology. 48: 401-6. PMID 2463494 DOI: 10.1159/000125041 |
0.112 |
|
1971 |
Murphy DL, Goodwin FK, Bunney WE. Leukocytosis during lithium treatment. The American Journal of Psychiatry. 127: 1559-61. PMID 5551533 DOI: 10.1176/Ajp.127.11.1559 |
0.112 |
|
1999 |
Altemus M, Jacobson KR, Debellis M, Kling M, Pigott T, Murphy DL, Gold PW. Normal CSF oxytocin and NPY levels in OCD. Biological Psychiatry. 45: 931-3. PMID 10202583 DOI: 10.1016/S0006-3223(98)00263-7 |
0.111 |
|
1975 |
Costa JL, Murphy DL. Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature. 255: 407-8. PMID 1128701 DOI: 10.1038/255407A0 |
0.111 |
|
1977 |
Costa JL, Murphy DL. Alterations in Human-Platelet Serotonin Uptake Following the Addition of Thrombin or A 23187 Thrombosis and Haemostasis. 37: 177-179. DOI: 10.1055/S-0038-1649216 |
0.111 |
|
1997 |
Constantino JN, Morris JA, Murphy DL. CSF 5-HIAA and family history of antisocial personality disorder in newborns. The American Journal of Psychiatry. 154: 1771-3. PMID 9396964 DOI: 10.1176/Ajp.154.12.1771 |
0.111 |
|
1975 |
Redmond DE, Murphy DL, Baulu J, Ziegler MG, Lake CR. Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine-beta-hydroxylase (DBH) activities in the rhesus monkey. Psychosomatic Medicine. 37: 417-28. PMID 808811 DOI: 10.1097/00006842-197509000-00005 |
0.111 |
|
1973 |
Donnelly EF, Murphy DL. Social desirability and bipolar affective disorder Journal of Consulting and Clinical Psychology. 41: 469. PMID 4803282 DOI: 10.1037/H0035354 |
0.111 |
|
1976 |
Donnelly EF, Murphy DL, Goodwin FK. Cross-sectional and longitudinal comparisons of bipolar and unipolar depressed groups on the MMPI Journal of Consulting and Clinical Psychology. 44: 233-237. PMID 1254756 DOI: 10.1037//0022-006X.44.2.233 |
0.111 |
|
1981 |
Kalin NH, Cohen RM, Kraemer GW, Risch SC, Shelton S, Cohen M, McKinney WT, Murphy DL. The dexamethasone suppression test as a measure of hypothalamic-pituitary feedback sensitivity and its relationship to behavioral arousal. Neuroendocrinology. 32: 92-5. PMID 7207702 DOI: 10.1159/000123137 |
0.111 |
|
1972 |
Bunney WE, Murphy DL, Goodwin FK, Borge GF. The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes. Archives of General Psychiatry. 27: 295-302. PMID 5051618 DOI: 10.1001/Archpsyc.1972.01750270005001 |
0.111 |
|
1980 |
Buchsbaum MS, Coursey RD, Murphy DL. Schizophrenia and platelet monoamine oxidase: research strategies. Schizophrenia Bulletin. 6: 375-84. PMID 6103578 DOI: 10.1093/Schbul/6.2.375 |
0.111 |
|
1987 |
Sunderland T, Rubinow DR, Tariot PN, Cohen RM, Newhouse PA, Mellow AM, Mueller EA, Murphy DL. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects. The American Journal of Psychiatry. 144: 1313-6. PMID 2889377 DOI: 10.1176/Ajp.144.10.1313 |
0.11 |
|
1993 |
Owen RR, Gutierrez-Esteinou R, Hsiao J, Hadd K, Benkelfat C, Lawlor BA, Murphy DL, Pickar D. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. Archives of General Psychiatry. 50: 636-44. PMID 8343034 DOI: 10.1001/Archpsyc.1993.01820200046005 |
0.11 |
|
1988 |
Aulakh CS, Zohar J, Wozniak KM, Hill JL, Murphy DL. Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes. European Journal of Pharmacology. 150: 239-46. PMID 2901357 DOI: 10.1016/0014-2999(88)90004-0 |
0.11 |
|
1982 |
Garbutt JC, van Kammen DP, Levine RA, Sternberg DE, Murphy DL, Ballenger J, Bunney WE, Lovenberg WM. Cerebrospinal fluid hydroxylase cofactor in schizophrenia. Psychiatry Research. 6: 145-51. PMID 6953456 DOI: 10.1016/0165-1781(82)90002-6 |
0.11 |
|
1994 |
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P. Organization of the human serotonin transporter gene Journal of Neural Transmission. 95: 157-162. PMID 7865169 DOI: 10.1007/Bf01276434 |
0.11 |
|
1985 |
Sunderland T, Tariot PN, Mueller EA, Newhouse PA, Murphy DL, Cohen RM. TRH stimulation test in dementia of the Alzheimer type and elderly controls. Psychiatry Research-Neuroimaging. 16: 269-275. PMID 3937167 DOI: 10.1016/0165-1781(85)90118-0 |
0.11 |
|
1996 |
Mazzola-Pomietto P, Aulakh CS, Murphy DL. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats. Psychopharmacology. 121: 488-93. PMID 8619014 DOI: 10.1007/Bf02246499 |
0.109 |
|
1973 |
Mendell JR, Murphy DL, Engel WK, Chase TN, Gordon E. Catecholamines and indoleamines in patients with Duchenne muscular dystrophy. Archives of Neurology. 27: 518-20. PMID 5083869 DOI: 10.1001/Archneur.1972.00490180054012 |
0.109 |
|
2002 |
Unger EL, Mazzola-Pomietto P, Murphy DL, Andrews AM. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine]. The Journal of Pharmacology and Experimental Therapeutics. 303: 527-33. PMID 12388632 DOI: 10.1124/Jpet.102.037614 |
0.109 |
|
1996 |
Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Murphy DL. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology. 123: 333-9. PMID 8867872 DOI: 10.1007/Bf02246643 |
0.109 |
|
2008 |
Kalueff AV, Keisala T, Minasyan A, Kumar SR, LaPorte JL, Murphy DL, Tuohimaa P. The regular and light-dark Suok tests of anxiety and sensorimotor integration: utility for behavioral characterization in laboratory rodents. Nature Protocols. 3: 129-36. PMID 18193029 DOI: 10.1038/Nprot.2007.516 |
0.109 |
|
2015 |
Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, ... ... Murphy DL, et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. The American Journal of Psychiatry. 172: 82-93. PMID 25158072 DOI: 10.1176/Appi.Ajp.2014.13101306 |
0.109 |
|
1986 |
Tariot PN, Sunderland T, Weingartner H, Murphy DL, Cohen MR, Cohen RM. Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of doses. Archives of General Psychiatry. 43: 727-32. PMID 3729666 DOI: 10.1001/Archpsyc.1986.01800080013002 |
0.109 |
|
1984 |
Siever LJ, Uhde TW, Jimerson DC, Lake CR, Silberman ER, Post RM, Murphy DL. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. The American Journal of Psychiatry. 141: 733-41. PMID 6329004 DOI: 10.1176/AJP.141.6.733 |
0.109 |
|
2003 |
Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL, Moe PR, Samavedy N, El-Mallakh R, Manji H, Glitz DA, Meyer ET, Smiley C, Hahn R, Widmark C, ... ... Murphy DL, et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. American Journal of Human Genetics. 73: 107-14. PMID 12772088 DOI: 10.1086/376562 |
0.109 |
|
2015 |
Riddle MA, Maher BS, Wang Y, Grados M, Bienvenu OJ, Goes FS, Cullen B, Murphy DL, Rauch SL, Greenberg BD, Knowles JA, McCracken JT, Pinto A, Piacentini J, Pauls DL, et al. OBSESSIVE-COMPULSIVE PERSONALITY DISORDER: EVIDENCE FOR TWO DIMENSIONS. Depression and Anxiety. PMID 26594839 DOI: 10.1002/Da.22452 |
0.109 |
|
1978 |
Costa JL, Stark H, Shafer B, Corash L, Smith MA, Murphy DL. Maximal packet size for serotonin in storage vesicles of intact human platelets. Life Sciences. 23: 2193-7. PMID 723471 DOI: 10.1016/0024-3205(78)90203-5 |
0.109 |
|
2013 |
Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, ... ... Murphy DL, et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. Plos Genetics. 9: e1003864. PMID 24204291 DOI: 10.1371/Journal.Pgen.1003864 |
0.108 |
|
1998 |
Murphy DL, Sims K, Eisenhofer G, Greenberg BD, George T, Berlin F, Zametkin A, Ernst M, Breakefield XO. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon? Journal of Neural Transmission. Supplementum. 52: 29-38. PMID 9564605 DOI: 10.1007/978-3-7091-6499-0_4 |
0.108 |
|
1975 |
Carpenter WT, Murphy DL, Wyatt RJ. Platelet monoamine oxidase activity in acute schizophrenia. The American Journal of Psychiatry. 132: 438-41. PMID 1119597 DOI: 10.1176/ajp.132.4.438 |
0.108 |
|
1999 |
Constantino JN, Murphy DL, Morris JA. Family psychiatric history, cerebrospinal fluid monoamine metabolites, and temperament in infants. Biological Psychiatry. 45: 626-32. PMID 10088050 DOI: 10.1016/S0006-3223(98)00170-X |
0.108 |
|
1993 |
Aulakh CS, Hill JL, Murphy DL. Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs. European Journal of Pharmacology. 240: 85-8. PMID 8405126 DOI: 10.1016/0014-2999(93)90550-2 |
0.108 |
|
1992 |
Collins FA, Murphy DL, Reiss AL, Sims KB, Lewis JG, Freund L, Karoum F, Zhu D, Maumenee IH, Antonarakis SE. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. American Journal of Medical Genetics. 42: 127-34. PMID 1308352 DOI: 10.1002/Ajmg.1320420126 |
0.108 |
|
2009 |
Kalueff AV, Ren-Patterson RF, LaPorte JL, Murphy DL. Domain-oriented analysis for understanding molecular interactions and translating animal genetic models into neuropsychiatric disorders: Focus on serotonin transporter and BDNF Animal Genetics. 197-220. |
0.108 |
|
1973 |
Murphy DL. Technical strategies for the study of catecholamines in man Life Sciences. 13: 1077-1082. DOI: 10.1016/0024-3205(73)90099-4 |
0.108 |
|
1997 |
Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 276-84. PMID 9094145 DOI: 10.1016/S0893-133X(96)00243-6 |
0.108 |
|
1989 |
Wozniak KM, Aulakh CS, Hill JL, Murphy DL. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats. Pharmacology, Biochemistry, and Behavior. 33: 265-7. PMID 2780783 DOI: 10.1016/0091-3057(89)90461-9 |
0.108 |
|
1996 |
Aulakh CS, Mazzola-Pomietto P, Murphy DL. Long-term antidepressant treatments alter 5-HT2A and 5-HT2C receptor-mediated hyperthermia in Fawn-Hooded rats. European Journal of Pharmacology. 282: 65-70. PMID 7498290 DOI: 10.1016/0014-2999(95)00279-T |
0.108 |
|
1995 |
Schwartz PJ, Wehr TA, Rosenthal NE, Bartko JJ, Oren DA, Luetke C, Murphy DL. Serotonin and thermoregulation. Physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 13: 105-15. PMID 8597522 DOI: 10.1016/0893-133X(95)00026-A |
0.108 |
|
2013 |
Fox MA, Panessiti MG, Hall FS, Uhl GR, Murphy DL. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice. Psychopharmacology. 227: 685-95. PMID 23417514 DOI: 10.1007/S00213-013-2988-X |
0.108 |
|
2000 |
Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J, Lesch KP, Hamer D, Murphy DL. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. American Journal of Medical Genetics. 96: 202-16. PMID 10893498 DOI: 10.1002/(Sici)1096-8628(20000403)96:2<202::Aid-Ajmg16>3.0.Co;2-J |
0.107 |
|
2003 |
Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity. Molecular Pharmacology. 64: 440-6. PMID 12869649 DOI: 10.1124/Mol.64.2.440 |
0.107 |
|
1974 |
Murphy DL, Goodwin FK, Bunney WE. Clinical and pharmacological investigations of the psychobiology of the affective disorders. International Pharmacopsychiatry. 6: 137-46. PMID 4150691 DOI: 10.1159/000468266 |
0.107 |
|
1993 |
Rubenstein CS, Pigott TA, Altemus M, L’Heureux F, Gray JJ, Murphy DL. High rates of comorbid ocd in patients with bulimia nervosa Eating Disorders. 1: 147-155. DOI: 10.1080/10640269308248282 |
0.107 |
|
1980 |
Zuckerman M, Buchsbaum MS, Murphy DL. Sensation seeking and its biological correlates Psychological Bulletin. 88: 187-214. DOI: 10.1037/0033-2909.88.1.187 |
0.107 |
|
2011 |
Timpano KR, Schmidt NB, Wheaton MG, Wendland JR, Murphy DL. Consideration of the BDNF gene in relation to two phenotypes: hoarding and obesity. Journal of Abnormal Psychology. 120: 700-7. PMID 21668081 DOI: 10.1037/A0024159 |
0.107 |
|
1979 |
Donnelly EF, Murphy DL, Waldman IN, Goodwin FK. Prediction of antidepressant responses to imipramine. Neuropsychobiology. 5: 94-101. PMID 431801 |
0.107 |
|
2000 |
Li Q, Wichems C, Heils A, Lesch KP, Murphy DL. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7888-95. PMID 11050108 DOI: 10.1523/Jneurosci.20-21-07888.2000 |
0.107 |
|
1977 |
Donnelly CH, Murphy DL. Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochemical Pharmacology. 26: 853-8. PMID 861051 DOI: 10.1016/0006-2952(77)90398-7 |
0.107 |
|
1973 |
Wyatt RJ, Murphy DL, Belmaker R, Cohen S, Donnelly CH, Pollin W. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Science (New York, N.Y.). 179: 916-8. PMID 4687789 DOI: 10.1126/Science.179.4076.916 |
0.107 |
|
1997 |
Su TP, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 346-56. PMID 9109106 DOI: 10.1016/S0893-133X(96)00245-X |
0.107 |
|
1990 |
Insel TR, Zohar J, Benkelfat C, Murphy DL. Serotonin in obsessions, compulsions, and the control of aggressive impulses. Annals of the New York Academy of Sciences. 600: 574-85; discussion 5. PMID 2252336 DOI: 10.1111/J.1749-6632.1990.Tb16911.X |
0.107 |
|
1973 |
Lott IT, Murphy DL, Chase TN. Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin. Neurology. 22: 967-72. PMID 4263686 DOI: 10.1212/Wnl.22.9.967 |
0.106 |
|
1977 |
Beckmann H, Murphy DL. Phenelzine in Depressed Patients Neuropsychobiology. 3: 49-55. PMID 895998 DOI: 10.1159/000117589 |
0.106 |
|
1984 |
DeLisi LE, Murphy DL, Karoum F, Mueller E, Targum S, Wyatt RJ. Phenylethylamine excretion in depression. Psychiatry Research. 13: 193-201. PMID 6597458 DOI: 10.1016/0165-1781(84)90034-9 |
0.106 |
|
1982 |
Taylor PL, Garrick NA, Burns RS, Tamarkin L, Murphy DL, Markey SP. Diurnal rhythms of serotonin in monkey cerebrospinal fluid Life Sciences. 31: 1993-1999. PMID 7176807 DOI: 10.1016/0024-3205(82)90038-8 |
0.106 |
|
2009 |
Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL, D'Ercole AJ, Crawley JN, Magnuson TR, Lauder JM. Social approach in genetically engineered mouse lines relevant to autism. Genes, Brain, and Behavior. 8: 129-42. PMID 19016890 DOI: 10.1111/J.1601-183X.2008.00452.X |
0.106 |
|
2007 |
Altamura C, Dell'Acqua ML, Moessner R, Murphy DL, Lesch KP, Persico AM. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cerebral Cortex (New York, N.Y. : 1991). 17: 1394-401. PMID 16905592 DOI: 10.1093/Cercor/Bhl051 |
0.106 |
|
2008 |
Schooler C, Revell AJ, Timpano KR, Wheaton M, Murphy DL. Predicting genetic loading from symptom patterns in obsessive- compulsive disorder: a latent variable analysis. Depression and Anxiety. 25: 680-8. PMID 18729144 DOI: 10.1002/Da.20444 |
0.106 |
|
1971 |
Bunney WE, Brodie HK, Murphy DL, Goodwin FK. Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania. The American Journal of Psychiatry. 127: 872-81. PMID 4924778 DOI: 10.1176/Ajp.127.7.872 |
0.106 |
|
1996 |
Lenders JW, Eisenhofer G, Abeling NG, Berger W, Murphy DL, Konings CH, Wagemakers LM, Kopin IJ, Karoum F, van Gennip AH, Brunner HG. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. The Journal of Clinical Investigation. 97: 1010-9. PMID 8613523 DOI: 10.1172/Jci118492 |
0.106 |
|
1980 |
Robinson DS, Campbell IC, Walker M, Statham NJ, Lovenberg W, Murphy DL. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain. Neuropharmacology. 18: 771-6. PMID 42024 DOI: 10.1016/0028-3908(79)90021-2 |
0.106 |
|
2014 |
McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, ... ... Murphy DL, et al. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 910-9. PMID 25062598 DOI: 10.1016/J.Jaac.2014.04.022 |
0.106 |
|
1994 |
Greenberg B, Benjamin J, Murphy D. Biphasic effects of metergoline in fluoxetine-treated OCD patients Biological Psychiatry. 35: 738. DOI: 10.1016/0006-3223(94)91102-9 |
0.106 |
|
1987 |
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Archives of General Psychiatry. 44: 418-26. PMID 3579494 DOI: 10.1097/00002093-198701040-00036 |
0.106 |
|
1989 |
Irving JB, Coursey RD, Buchsbaum MS, Murphy DL. Platelet monoamine oxidase activity and life stress as predictors of psychopathology and coping in a community sample. Psychological Medicine. 19: 79-90. PMID 2727212 DOI: 10.1017/S0033291700011041 |
0.105 |
|
1975 |
Murphy DL, Beigel A. Depression, elation, and lithium carbonate responses in manic patient subgroups. Archives of General Psychiatry. 31: 643-8. PMID 4441238 DOI: 10.1001/Archpsyc.1974.01760170043007 |
0.105 |
|
2000 |
Sher L, Greenberg BD, Murphy DL, Rosenthal NE, Sirota LA, Hamer DH. Pleiotropy of the serotonin transporter gene for seasonality and neuroticism. Psychiatric Genetics. 10: 125-30. PMID 11204348 DOI: 10.1097/00041444-200010030-00004 |
0.105 |
|
1977 |
Murphy DL, Belmaker R, Carpenter WT, Wyatt RJ. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity. The British Journal of Psychiatry : the Journal of Mental Science. 130: 151-8. PMID 319862 DOI: 10.1192/Bjp.130.2.151 |
0.105 |
|
2004 |
Cichon S, Buervenich S, Kirov G, Akula N, Dimitrova A, Green E, Schumacher J, Klopp N, Becker T, Ohlraun S, Schulze TG, Tullius M, Gross MM, Jones L, Krastev S, ... ... Murphy DL, et al. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nature Genetics. 36: 783-4; author reply . PMID 15284840 DOI: 10.1038/Ng0804-783 |
0.105 |
|
1973 |
Donnelly EF, Murphy DL. Primary affective disorder: MMPI differences between unipolar and bipolar depressed subjects Journal of Clinical Psychology. 29: 303-306. PMID 4146929 DOI: 10.1002/1097-4679(197307)29:3<303::Aid-Jclp2270290307>3.0.Co;2-F |
0.105 |
|
1978 |
Donnelly EF, Goodwin FK, Waldman IN, Murphy DL. Prediction of antidepressant responses to lithium. The American Journal of Psychiatry. 135: 552-6. PMID 645948 |
0.105 |
|
1979 |
Wyatt RJ, Potkin SG, Murphy DL. Platelet monoamine oxidase activity in schizophrenia: A review of the data American Journal of Psychiatry. 136: 377-385. PMID 371419 |
0.105 |
|
1984 |
Aulakh CS, Cohen RM, McLellan C, Murphy DL. Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation. British Journal of Pharmacology. 80: 10-2. PMID 6317126 DOI: 10.1111/J.1476-5381.1983.Tb11042.X |
0.105 |
|
2007 |
Hasler G, Pinto A, Greenberg BD, Samuels J, Fyer AJ, Pauls D, Knowles JA, McCracken JT, Piacentini J, Riddle MA, Rauch SL, Rasmussen SA, Willour VL, Grados MA, Cullen B, ... ... Murphy DL, et al. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biological Psychiatry. 61: 617-25. PMID 17027929 DOI: 10.1016/J.Biopsych.2006.05.040 |
0.104 |
|
2005 |
Ren-Patterson RF, Kim DK, Zheng X, Sherrill S, Huang SJ, Tolliver T, Murphy DL. Serotonergic-like progenitor cells propagated from neural stem cells in vitro: survival with SERT protein expression following implantation into brains of mice lacking SERT. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1537-9. PMID 15972295 DOI: 10.1096/Fj.04-3657Fje |
0.104 |
|
2001 |
Ravary A, Muzerelle A, Darmon M, Murphy DL, Moessner R, Lesch KP, Gaspar P. Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein. The European Journal of Neuroscience. 13: 1349-62. PMID 11298795 DOI: 10.1046/J.0953-816X.2001.1511.X |
0.104 |
|
1975 |
Belmaker R, Beckmann H, Goodwin F, Murphy D, Pollin W, Buchsbaum M, Wyatt R, Ciaranello R, Lamprecht F. Relationships between platelet and plasma monoamine oxidase, plasma dopamine-B-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol Life Sciences. 16: 273-279. PMID 1110604 DOI: 10.1016/0024-3205(75)90025-9 |
0.104 |
|
1986 |
Siever LJ, Uhde TW, Jimerson DC, Lake CR, Kopin IJ, Murphy DL. Indices of noradrenergic output in depression. Psychiatry Research. 19: 59-73. PMID 3786600 DOI: 10.1016/0165-1781(86)90093-4 |
0.103 |
|
2000 |
Sher L, Hamer D, Greenberg B, Murphy D, Rosenthal N. 256. The serotonin transporter gene influences seasonality independently of personality Biological Psychiatry. 47: S78. DOI: 10.1016/S0006-3223(00)00520-5 |
0.103 |
|
1970 |
Baer L, Durell J, Bunney WE, Levy BS, Murphy DL, Greenspan K, Cardon PV. Sodium balance and distribution in lithium carbonate therapy. Archives of General Psychiatry. 22: 40-4. PMID 5409519 DOI: 10.1001/Archpsyc.1970.01740250042007 |
0.103 |
|
1981 |
Costa JL, Kirk KL, Murphy DL, Stark H. Anomalous compartmentation of 5-hydroxytryptamine in intact human platelets. British Journal of Pharmacology. 72: 449-59. PMID 7260486 DOI: 10.1111/J.1476-5381.1981.Tb10996.X |
0.103 |
|
1992 |
Aulakh CS, Hill JL, Yoney HT, Murphy DL. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) Psychopharmacology. 109: 444-448. PMID 1365860 DOI: 10.1007/Bf02247721 |
0.103 |
|
1981 |
Pickar D, Cohen RM, Jimerson DC, Lake CR, Murphy DL. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction. Psychopharmacology. 74: 8-12. PMID 6791210 DOI: 10.1007/BF00431748 |
0.103 |
|
1997 |
Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. The Journal of Clinical Endocrinology and Metabolism. 82: 1220-8. PMID 9100599 DOI: 10.1210/Jcem.82.4.3905 |
0.103 |
|
2001 |
Wassermann EM, Greenberg BD, Nguyen MB, Murphy DL. Motor cortex excitability correlates with an anxiety-related personality trait. Biological Psychiatry. 50: 377-82. PMID 11543742 DOI: 10.1016/S0006-3223(01)01210-0 |
0.103 |
|
1982 |
Coursey RD, Buchsbaum MS, Murphy DL. 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO. Neuropsychobiology. 8: 51-6. PMID 7073872 DOI: 10.1159/000117877 |
0.103 |
|
1997 |
Bengel D, Jöhren O, Andrews AM, Heils A, Mössner R, Sanvitto GL, Saavedra JM, Lesch KP, Murphy DL. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Research. 778: 338-45. PMID 9459551 DOI: 10.1016/S0006-8993(97)01080-9 |
0.103 |
|
1985 |
Garrick NA, Seppala T, Linnoila M, Murphy DL. Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone. Psychopharmacology. 86: 265-9. PMID 2412251 DOI: 10.1007/Bf00432211 |
0.103 |
|
1982 |
Cohen RM, Aulakh CS, Campbell IC, Murphy DL. Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment. European Journal of Pharmacology. 81: 145-8. PMID 6288399 DOI: 10.1016/0014-2999(82)90614-8 |
0.103 |
|
1996 |
Altemus M, Glowa JR, Galliven E, Leong YM, Murphy DL. Effects of serotonergic agents on food-restriction - Induced hyperactivity Pharmacology Biochemistry and Behavior. 53: 123-131. PMID 8848441 DOI: 10.1016/0091-3057(95)02003-9 |
0.102 |
|
1974 |
Donnelly EF, Murphy DL. Primary affective disorder: Bender Gestalt sequence of placement as an indicator of impulse control Perceptual and Motor Skills. 38: 1079-1082. PMID 4153610 DOI: 10.2466/Pms.1974.38.3C.1079 |
0.102 |
|
1988 |
Tariot PN, Cohen RM, Welkowitz JA, Sunderland T, Newhouse PA, Murphy DL, Weingartner H. Multiple-dose arecoline infusions in Alzheimer's disease. Archives of General Psychiatry. 45: 901-5. PMID 3048224 DOI: 10.1001/Archpsyc.1988.01800340023003 |
0.102 |
|
1989 |
Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, Newhouse PA, Cohen MR, Murphy DL. Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease. Psychopharmacology. 98: 403-7. PMID 2501817 DOI: 10.1007/Bf00451695 |
0.102 |
|
1989 |
Berrettini WH, Garrick NA, Nurnberger JI, Simmons-Alling S, Gelernter J, Gold PW, Rubinow DR, Murphy DL. Intravenous physostigmine increases cerebrospinal fluid neuropeptide-Y. Biological Psychiatry. 26: 623-30. PMID 2790099 DOI: 10.1016/0006-3223(89)90087-5 |
0.102 |
|
2012 |
Lerner A, Bagic A, Simmons JM, Mari Z, Bonne O, Xu B, Kazuba D, Herscovitch P, Carson RE, Murphy DL, Drevets WC, Hallett M. Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain : a Journal of Neurology. 135: 1926-36. PMID 22577221 DOI: 10.1093/Brain/Aws104 |
0.102 |
|
1999 |
Clarke RA, Murphy DL, Constantino JN. Serotonin and externalizing behavior in young children. Psychiatry Research. 86: 29-40. PMID 10359480 DOI: 10.1016/S0165-1781(99)00022-0 |
0.102 |
|
2014 |
Samuels J, Shugart YY, Wang Y, Grados MA, Bienvenu OJ, Pinto A, Rauch SL, Greenberg BD, Knowles JA, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Rasmussen SA, Stewart SE, ... ... Murphy DL, et al. Clinical correlates and genetic linkage of social and communication difficulties in families with obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 165: 326-36. PMID 24798771 DOI: 10.1002/Ajmg.B.32235 |
0.102 |
|
1980 |
Cohen RM, Pickar D, Murphy DL. Myoclonus-associated hypomania during MAO-inhibitor-treatment American Journal of Psychiatry. 137: 105-106. PMID 7352541 |
0.101 |
|
2012 |
Aulakh CS, Hill JL, Tolliver TJ, Marcantonio D, Murphy DL. Long-term administration of m-chlorophenylpiperazine to rats does not alter functional sensitivity of either pre-synaptic or postsynaptic 5-HT1A receptors. Journal of Psychopharmacology (Oxford, England). 5: 142-8. PMID 22282366 DOI: 10.1177/026988119100500208 |
0.101 |
|
2006 |
Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics. 78: 815-26. PMID 16642437 DOI: 10.1086/503850 |
0.101 |
|
1996 |
Wiggs CL, Martin A, Altemus M, Murphy DL. Hypervigilance in patients with obsessive-compulsive disorder. Anxiety. 2: 123-9. PMID 9160613 DOI: 10.1002/(Sici)1522-7154(1996)2:3<123::Aid-Anxi3>3.0.Co;2-Q |
0.101 |
|
1991 |
PIGOTT TA, PATO MT, L??HEUREUX F, HILL JL, GROVER GN, BERNSTEIN SE, MURPHY DL. A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine-Treated Patients with Obsessive-Compulsive Disorder Journal of Clinical Psychopharmacology. 11: 242???248. DOI: 10.1097/00004714-199108000-00004 |
0.101 |
|
1986 |
Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clinical Chemistry. 32: 2030-3. PMID 3096593 DOI: 10.1093/Clinchem/32.11.2030 |
0.1 |
|
1989 |
Aulakh CS, Wozniak KM, Hill JL, Murphy DL. Differential effects of long-term antidepressant treatments on 8-OHDPAT-induced increases in plasma prolactin and corticosterone in rats. European Journal of Pharmacology. 156: 395-400. PMID 2975226 DOI: 10.1016/0014-2999(88)90285-3 |
0.1 |
|
1979 |
Murphy DL, Lipper S, Slater S, Shiling D. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Psychopharmacology. 62: 129-32. PMID 111275 DOI: 10.1007/Bf00427125 |
0.1 |
|
1977 |
Bunney WE, Murphy DL. Neurobiological Considerations of the mode of action of lithium carbonate in the treatment of affective disorders? Pharmakopsychiatrie, Neuro-Psychopharmakologie. 9: 142-7. PMID 185630 DOI: 10.1055/s-0028-1094489 |
0.1 |
|
1978 |
Van Kammen DP, Marder SR, Murphy DL, Bunney WE. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia. The American Journal of Psychiatry. 135: 567-9. PMID 645949 DOI: 10.1176/AJP.135.5.567 |
0.1 |
|
2011 |
Voyiaziakis E, Evgrafov O, Li D, Yoon HJ, Tabares P, Samuels J, Wang Y, Riddle MA, Grados MA, Bienvenu OJ, Shugart YY, Liang KY, Greenberg BD, Rasmussen SA, Murphy DL, et al. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Molecular Psychiatry. 16: 108-20. PMID 19806148 DOI: 10.1038/Mp.2009.100 |
0.1 |
|
2000 |
Schmidt NB, Storey J, Greenberg BD, Santiago HT, Li Q, Murphy DL. Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach. Journal of Abnormal Psychology. 109: 308-20. PMID 10895569 DOI: 10.1037/0021-843X.109.2.308 |
0.1 |
|
1979 |
Redmond DE, Murphy DL, Baulu J. Platelet monoamine oxidase activity correlates with social affiliative and agonistic behaviors in normal rhesus monkeys. Psychosomatic Medicine. 41: 87-100. PMID 108757 DOI: 10.1097/00006842-197903000-00002 |
0.1 |
|
2013 |
Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O'Dushlaine C, Fagerness JA, Yu D, Scharf JM, Chan E, Kassam F, Moya PR, Wendland JR, Delorme R, Richter MA, Kennedy JL, ... ... Murphy DL, et al. Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 367-79. PMID 23606572 DOI: 10.1002/Ajmg.B.32137 |
0.1 |
|
1976 |
Costa JL, Murphy DL. Changes in human-platelet storage packet size following incubation with labelled serotonin. Life Sciences. 18: 1413-7. PMID 940422 DOI: 10.1016/0024-3205(76)90358-1 |
0.1 |
|
1988 |
Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J, Murphy DL. Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. European Journal of Pharmacology. 146: 253-9. PMID 2967188 DOI: 10.1016/0014-2999(88)90300-7 |
0.099 |
|
1995 |
Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JW. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clinical Science (London, England : 1979). 88: 533-42. PMID 7614812 DOI: 10.1042/Cs0880533 |
0.099 |
|
2004 |
Shen HW, Hagino Y, Kobayashi H, Shinohara-Tanaka K, Ikeda K, Yamamoto H, Yamamoto T, Lesch KP, Murphy DL, Hall FS, Uhl GR, Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1790-9. PMID 15226739 DOI: 10.1038/Sj.Npp.1300476 |
0.099 |
|
1986 |
Tariot PN, Sunderland T, Murphy DL, Cohen MR, Welkowitz JA, Weingartner H, Newhouse PA, Cohen RM. Design and interpretation of opiate antagonist trials in dementia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 611-26. PMID 3025928 DOI: 10.1016/0278-5846(86)90031-X |
0.099 |
|
2008 |
Samuels JF, Bienvenu OJ, Pinto A, Murphy DL, Piacentini J, Rauch SL, Fyer AJ, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Cullen B, Riddle MA, Rasmussen SA, Pauls DL, et al. Sex-specific clinical correlates of hoarding in obsessive-compulsive disorder. Behaviour Research and Therapy. 46: 1040-6. PMID 18692168 DOI: 10.1016/J.Brat.2008.06.005 |
0.099 |
|
2011 |
Hall FS, Schwarzbaum JM, Perona MT, Templin JS, Caron MG, Lesch KP, Murphy DL, Uhl GR. A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception. Neuroscience. 175: 315-27. PMID 21129446 DOI: 10.1016/J.Neuroscience.2010.11.057 |
0.099 |
|
2008 |
Murphy DL. Starting with serotonin: How a high-rolling father of drug discovery repeatedly beat the odds Journal of Clinical Investigation. 118: 3819-3819. DOI: 10.1172/Jci37536 |
0.099 |
|
1976 |
Murphy DL, Donnelly CH, Miller L, Wyatt RJ. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity. Archives of General Psychiatry. 33: 1377-81. PMID 985048 DOI: 10.1001/Archpsyc.1976.01770110105011 |
0.099 |
|
2015 |
Qin H, Samuels JF, Wang Y, Zhu Y, Grados MA, Riddle MA, Greenberg BD, Knowles JA, Fyer AJ, McCracken JT, Murphy DL, Rasmussen SA, Cullen BA, Piacentini J, Geller D, et al. Whole-genome association analysis of treatment response in obsessive-compulsive disorder. Molecular Psychiatry. PMID 25824302 DOI: 10.1038/mp.2015.32 |
0.099 |
|
1985 |
Sunderland T, Tariot P, Murphy DL, Weingartner H, Mueller EA, Cohen RM. Scopolamine challenges in Alzheimer's disease. Psychopharmacology. 87: 247-9. PMID 3931154 DOI: 10.1007/Bf00431817 |
0.099 |
|
1988 |
Tariot PN, Gross M, Sunderland T, Cohen MR, Weingartner H, Murphy DL, Cohen RM. High-dose naloxone in older normal subjects: implications for Alzheimer's disease. Journal of the American Geriatrics Society. 36: 681-6. PMID 3042841 DOI: 10.1111/J.1532-5415.1988.Tb07168.X |
0.098 |
|
1989 |
Siever LJ, Coursey RD, Alterman IS, Zahn T, Brody L, Bernad P, Buchsbaum M, Lake CR, Murphy DL. Clinical, psychophysiological, and neurological characteristics of volunteers with impaired smooth pursuit eye movements. Biological Psychiatry. 26: 35-51. PMID 2720022 DOI: 10.1016/0006-3223(89)90006-1 |
0.098 |
|
1991 |
Newman JD, Winslow JT, Murphy DL. Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibition. Brain Research. 538: 24-8. PMID 1902133 DOI: 10.1016/0006-8993(91)90371-2 |
0.098 |
|
1976 |
Spiegel AM, Gerner RH, Murphy DL, Aurbach GD. Lithium does not inhibit the parathyroid hormone-mediated rise in urinary cyclic AMP and phosphate in humans. The Journal of Clinical Endocrinology and Metabolism. 43: 1390-3. PMID 187615 DOI: 10.1210/Jcem-43-6-1390 |
0.098 |
|
1977 |
Lake CR, Ziegler MG, Eldridge R, Murphy DL. Catecholamine metabolism in Gilles de la Tourette's syndrome. The American Journal of Psychiatry. 134: 257-60. PMID 265141 DOI: 10.1176/AJP.134.3.257 |
0.098 |
|
2014 |
Rudnick G, Krämer R, Blakely RD, Murphy DL, Verrey F. The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Pflã¼Gers Archiv : European Journal of Physiology. 466: 25-42. PMID 24337881 DOI: 10.1007/S00424-013-1410-1 |
0.098 |
|
1982 |
Risch SC, Janowsky DS, Siever LJ, Judd LJ, Rausch JL, Huey LY, Beckman KA, Cohen RM, Murphy DL. Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans. Peptides. 3: 319-22. PMID 6289276 DOI: 10.1016/0196-9781(82)90093-6 |
0.098 |
|
1985 |
Campbell IC, Gallager DW, Hamburg MA, Tallman JF, Murphy DL. Electrophysiological and receptor studies in rat brain: effects of clorgyline. European Journal of Pharmacology. 111: 355-64. PMID 2990957 DOI: 10.1016/0014-2999(85)90642-9 |
0.098 |
|
1987 |
Tariot PN, Sunderland T, Weingartner H, Murphy DL, Welkowitz JA, Thompson K, Cohen RM. Cognitive effects of L-deprenyl in Alzheimer's disease. Psychopharmacology. 91: 489-95. PMID 3108930 DOI: 10.1007/Bf00216016 |
0.098 |
|
1998 |
Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). Journal of Neural Transmission. Supplementum. 52: 39-48. PMID 9564606 DOI: 10.1007/978-3-7091-6499-0_5 |
0.098 |
|
2016 |
Park JM, Samuels JF, Grados MA, Riddle MA, Bienvenu OJ, Goes FS, Cullen B, Wang Y, Krasnow J, Murphy DL, Rasmussen SA, McLaughlin NC, Piacentini J, Pauls DL, Stewart SE, et al. ADHD and executive functioning deficits in OCD youths who hoard. Journal of Psychiatric Research. 82: 141-148. PMID 27501140 DOI: 10.1016/J.Jpsychires.2016.07.024 |
0.097 |
|
1974 |
Murphy DL, Donnelly C, Moskowitz J. Catecholamine Receptor Function in Depressed Patients American Journal of Psychiatry. 131: 1389-1391. DOI: 10.1176/Ajp.1974.131.12.1389 |
0.097 |
|
2017 |
Ritter ML, Guo W, Samuels JF, Wang Y, Nestadt PS, Krasnow J, Greenberg BD, Fyer AJ, McCracken JT, Geller DA, Murphy DL, Knowles JA, Grados MA, Riddle MA, Rasmussen SA, et al. Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD). Frontiers in Molecular Neuroscience. 10: 83. PMID 28386217 DOI: 10.3389/Fnmol.2017.00083 |
0.097 |
|
Hide low-probability matches. |